<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<TITLE>Sample LCModel Applications</TITLE>

<style type="text/css">
 body{
  margin:10;
  padding:10px 0 0 150px;
  padding:0 0 0 175px;
  background:#ccc;
  background:#e0ffff;
 }
 div#left-sidebar{
  position:absolute;
  top:10px;
  left:0;
  width:175px;
  background:#ccc;
  background:#e0ffff;
  color: #000;
 }
 div#content{
  background:#fff;
 }
 @media screen{
  body>div#left-sidebar{
   position:fixed;
  }
 }
 * html body{
  overflow:hidden;
 }
 * html div#content{
  height:100%;
  overflow:auto;
 }
</style>

</head>

<body>
<div id="left-sidebar">
 <ul>
 <li><a href="lcmodel.shtml.html">LCModel home</a></li><br>
 <hr>
 <li><a href="one-page.shtml.html">brain</a></li>
 <li><a href="fig-weak-naa.shtml.html">brain tumor</a></li>
 <li><a href="fig-strong-lipid.shtml.html">brain + lipids</a></li>
 <li><a href="fig-lipid-1.shtml.html">bone</a></li>
 <li><a href="fig-breast-1.shtml.html">breast</a></li>
 <li><a href="fig-liver-1.shtml.html">liver</a></li>
 <li><a href="fig-muscle.shtml.html">muscle</a></li>
 <li><a href="fig-mega.shtml.html">MEGA-PRESS</a></li><br>
 <hr>
 <li><a href="lcm-test.shtml.html">free download</a></li>
 <li><a href="lcm-license.shtml.html">license</a></li>
 <li><a href="lcm-applications.shtml.html">early applications</a></li>
 <li><a href="file-selector.shtml.html">analysis Step 1</a></li>
 <li><a href="control-parameters.shtml.html">analysis Step 2</a></li>
 <li><a href="lcm-manual.shtml.html">user manual</a></li>
 <li><a href="asia.shtml.html">Japan and China</a></li>
 </ul>
</div>


<div id="content">
<CENTER><H2>Some Applications of LCModel (to 2005)</H2></CENTER>
<FONT SIZE="3">
<UL>

   <LI>Discrimination of white matter lesions and multiple sclerosis plaques 
by short echo quantitative H-1 - magnetic resonance spectroscopy<BR> 
Kapeller, P; Ropele, S; Enzinger, C; Lahousen, T; Strasser-Fuchs, S; 
Schmidt, R; Fazekas, F<BR> 
<I>J Neurology</I> <STRONG>10</STRONG>, 1229-1234 (2005).</LI>
<BR>
<BR>

   <LI>Automatic repositioning of single voxels in longitudinal H-1 MRS 
studies<BR> 
Hancu, I; Blezek, DJ; Dumoulin, MC<BR> 
<I>NMR Biomed</I> <STRONG>18</STRONG>, 352-361 (2005).</LI>
<BR>
<BR>

   <LI>Methodology of H-1 NMR spectroscopy of the human brain at very high 
magnetic fields<BR> 
Tkac, I; Gruetter, R<BR> 
<I>Appl Magn Reson</I> <STRONG>29</STRONG>, 139-157 (2005).</LI>
<BR>
<BR>

   <LI>Quantitative proton MRS of Pelizaeus-Merzbacher disease - Evidence of 
dys- and hypomyelination<BR> 
Hanefeld, FA; Brockmann, K; Pouwels, PJW; Wilken, B; Frahm, J; Dechent, P<BR> 
<I>Neurology</I> <STRONG>65</STRONG>, 701-706 (2005).</LI>
<BR>
<BR>

   <LI>Metabolite changes in normal-appearing gray and white matter are linked 
with disability in early primary progressive multiple sclerosis<BR> 
Sastre-Garriga, J; Ingle, GT; Chard, DT; Ramio-Torrenta, L; McLean, MA; 
Miller, DH; Thompson, AJ<BR> 
<I>Arch Neurology</I> <STRONG>62</STRONG>, 569-573 (2005).</LI>
<BR>
<BR>

   <LI>Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in 
the human brain<BR> 
Jensen, JE; Frederick, BD; Wang, LQ; Brown, J; Renshaw, PF<BR> 
<I>Magn Reson Med</I> <STRONG>54</STRONG>, 783-788 (2005).</LI>
<BR>
<BR>

   <LI>Interindividual reproducibility of glutamate quantification using 1.5-T 
proton magnetic resonance spectroscopy<BR> 
Jang, DP; Lee, JM; Lee, E; Park, S; Kim, JJ; Namkoong, K; Yoon, KJ; Kim, IY; 
Kim, SI<BR> 
<I>Magn Reson Med</I> <STRONG>53</STRONG>, 708-712 (2005).</LI>
<BR>
<BR>

   <LI>	Altered metabolic profile in the frontal cortex of PS2APP transgenic 
mice, monitored throughout their life span<BR> 
von Kienlin, M; Kunnecke, B; Metzger, F; Steiner, G; Richards, JG; Ozmen, L; 
Jacobsen, H; Loetscher, H<BR> 
<I>Neurobiology of Disease</I> <STRONG>18</STRONG>, 32-39 (2005).</LI>
<BR>
<BR>

   <LI>Hippocampal myo-inositol and cognitive ability in adults with Down 
syndrome - An in vivo proton magnetic resonance spectroscopy study<BR> 
Beacher, F; Simmons, A; Daly, E; Prasher, V; Adams, C; Margallo-Lana, ML; 
Morris, R; Lovestone, S; Murphy, K; Murphy, DGM<BR> 
<I>Arch Gen Psychiatry</I> <STRONG>62</STRONG>, 1360-1365 (2005).</LI>
<BR>
<BR>

   <LI>Increased prefrontal and hippocampal glutamate concentration in 
schizophrenia: Evidence from a magnetic resonance spectroscopy study<BR> 
van Elst, LT; Valerius, G; Buchert, M; Thiel, T; Rusch, N; Bubl, E; Hennig, J; 
Ebert, D; Olbrich, HM<BR> 
<I>Biol Psychiatry</I> <STRONG>58</STRONG>, 724-730 (2005).</LI>
<BR>
<BR>

   <LI>Monitoring disease progression in transgenic mouse models of 
Alzheimer's disease with proton magnetic resonance spectroscopy<BR> 
Marjanska, M; Curran, GL; Wengenack, TM; Henry, PG; Bliss, RL; Poduslo, JF; 
Jack, CR; Ugurbil, K; Garwood, M<BR> 
<I>Proc Natl Acad Sci USA</I> <STRONG>102</STRONG>, 11906-11910 (2005).</LI>
<BR>
<BR>

   <LI>Grey and white matter GABA level differences in the human brain using 
two-dimensional, J-resolved spectroscopic imaging<BR> 
Jensen, JE; Frederick, BD; Renshaw, PF<BR> 
<I>NMR Biomed</I> <STRONG>18</STRONG>, 570-576 (2005).</LI>
<BR>
<BR>

   <LI>Growth restriction and the cerebral metabolic response to acute hypoxia 
of chick embryos in-ovo: A proton magnetic resonance spectroscopy study<BR> 
Dixon, JC; Cady, EB; Priest, AN; Thornton, JS; Peebles, DM<BR> 
<I>Developmental Brain Res</I> <STRONG>160</STRONG>, 203-210 (2005).</LI>
<BR>
<BR>

   <LI>Proton spectroscopy study of the left dorsolateral prefrontal cortex in 
pediatric depressed patients<BR> 
Caetano, SC; Fonseca, M; Olvera, RL; Nicoletti, M; Hatch, JP; Stanley, JA; 
Hunter, K; Lafer, B; Pliszka, SR; Soares, JC<BR> 
<I>Neurosci Lett</I> <STRONG>384</STRONG>, 321-326 (2005).</LI>
<BR>
<BR>

   <LI>Examining SLV-323, a novel NK1 receptor antagonist, in a chronic 
psychosocial stress model for depression<BR> 
Czeh, B; Pudovkina, O; van der Hart, MGC; Simon, M; Heilbronner, U; Michaelis, 
T; Watanabe, T; Frahm, J; Fuchs, E<BR> 
<I>Psychopharmacology</I> <STRONG>180</STRONG>, 548-557 (2005).</LI>
<BR>
<BR>

   <LI>Decreased prefrontal Myo-inositol in major depressive disorder<BR> 
Coupland, NJ; Ogilvie, CJ; Hegadoren, KM; Seres, P; Hanstock, CC; Allen, 
PS<BR> 
<I>Biol Psychiatry</I> <STRONG>57</STRONG>, 1526-1534 (2005).</LI>
<BR>
<BR>

   <LI>H-1 MR spectroscopic characteristics of kernicterus: A possible 
metabolic signature<BR> 
Oakden, WK; Moore, AM; Blaser, S; Noseworthy, MD<BR> 
<I>Amer J Neuroradiology</I> <STRONG>26</STRONG>, 1571-1574 (2005).</LI>
<BR>
<BR>

   <LI>In vivo effect of chronic hypoxia on the neurochemical profile of the 
developing rat hippocampus<BR> 
Raman, L; Tkac, I; Ennis, K; Georgieff, MK; Gruetter, R; Rao, R<BR> 
<I>Developmental Brain Res</I> <STRONG>156</STRONG>, 202-209 (2005).</LI>
<BR>
<BR>

   <LI>Statistical evaluation of time-dependent metabolite concentrations: 
estimation of post-mortem intervals based on in situ H-1-MRS the brain<BR> 
Scheurer, E; Ith, M; Dietrich, D; Kreis, R; Husler, J; Dirnhofer, R; Boesch, 
C<BR> 
<I>NMR Biomed</I> <STRONG>18</STRONG>, 163-172 (2005).</LI>
<BR>
<BR>

   <LI>Short TE single-voxel H-1-MR spectroscopy of hippocampal structures in 
healthy adults at 1.5 Tesla - how reproducible are the results?<BR> 
Hammen, T; Stadlbauer, A; Tomandl, B; Ganslandt, O; Pauli, E; Huk, W; 
Neundorfer, B; Stefan, H<BR> 
<I>NMR Biomed</I> <STRONG>18</STRONG>, 195-201 (2005).</LI>
<BR>
<BR>

   <LI>Magnetic resonance spectroscopy in patients with MELAS<BR> 
Moller, HE; Kurlemann, G; Putzler, M; Wiedermann, D; Hilbich, T; Fiedler, B<BR>
<I>J Neurological Sci</I> <STRONG>229</STRONG>, 131-139 (2005).</LI>
<BR>
<BR>

   <LI>Anterior cingulate neurochemistry in social anxiety disorder: H-1-MRS 
at 4 Tesla<BR> 
Phan, KL; Fitzgerald, DA; Cortese, BM; Seraji-Bozorgzad, N; Tancer, ME; Moore, 
GJ<BR> 
<I>Neuroreport</I> <STRONG>16</STRONG>, 183-186 (2005).</LI>
<BR>
<BR>

   <LI>H-1-MRS alterations in the cerebellum of patients with familial 
hemilegic migraine type 1<BR> 
Dichgans, M; Herzog, J; Freilinger, T; Wilke, M; Auer, DP<BR> 
<I>Neurology</I> <STRONG>64</STRONG>, 608-613 (2005).</LI>
<BR>
<BR>

   <LI>High-field localized H-1 NMR spectroscopy in the anesthetized and in 
the awake monkey<BR> 
Pfeuffer, J; Juchem, C; Merkle, H; Nauerth, A; Logothetis, NK<BR> 
<I>Magn Reson Imaging</I> <STRONG>22</STRONG>, 1361-1372 (2004).</LI>
<BR>
<BR>

   <LI>Region and volume dependencies in spectral line width assessed by H-1 
2D MR chemical shift imaging in the monkey brain at 7 T<BR> 
Juchem, C; Merkle, H; Schick, F; Logothetis, NK; Pfeuffer, J<BR> 
<I>Magn Reson Imaging</I> <STRONG>22</STRONG>, 1373-1383 (2004).</LI>
<BR>
<BR>

   <LI>Assessment of adrenoleukodystrophy lesions by high field MRS in 
non-sedated pediatric patients<BR> 
Oz, G; Tkac, I; Charnas, LR; Choi, IY; Bjoraker, KJ; Shapiro, EG; Gruetter, 
R<BR> 
<I>Neurology</I> <STRONG>64</STRONG>, 434-441 (2005).</LI>
<BR>
<BR>

   <LI>MR spectroscopic evidence for glial increase but not for neuro-axonal 
damage in MS normal-appearing white matter<BR> 
Vrenken, H; Barkhof, F; Uitdehaag, BMJ; Castelijns, JA; Polman, CH; Pouwels, 
PJW<BR> 
<I>Magn Reson Med</I> <STRONG>53</STRONG>, 256-266 (2005).</LI>
<BR>
<BR>

   <LI>Mapping of temporal and parietal cortex in progressive nonfluent 
aphasia and Alzheimer's disease using chemical shift imaging, voxel-based 
morphometry and positron emission tomography<BR> 
Zahn, R; Buechert, M; Overmans, J; Talazko, J; Specht, K; Ko, CW; Thiel, T; 
Kaufmann, R; Dykierek, P; Juengling, F; Hull, M<BR> 
<I>Psychiatry Res Neuroimaging</I> <STRONG>140</STRONG>, 115-131 (2005).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy and magnetoencephalographic 
estimation of delta dipole density: A combination of techniques that may 
contribute to the diagnosis of Alzheimer's disease<BR> 
Fernandez, A; Garcia-Segura, JM; Ortiz, T; Montoya, J; Maestu, F; 
Gil-Gregorio, P; Campo, P; Viano, J<BR> 
<I>Dementia Geriatric Cognitive Disorders</I> <STRONG>20</STRONG>, 169-177 
(2005).</LI>
<BR>
<BR>

   <LI>Brain mitochondrial injury in human immunodeficiency virus-seropositive 
(HIV+) individuals taking nucleoside reverse transcriptase inhibitors<BR> 
Schweinsburg, BC; Taylor, MJ; Alhassoon, OM; Gonzalez, R; Brown, GG; Ellis, 
RJ; Letendre, S; Videen, JS; McCutchan, JA; Patterson, TL; Grant, I 
HNRC Grp<BR> 
<I>J Neurovirology</I> <STRONG>11</STRONG>, 356-364 (2005).</LI>
<BR>
<BR>

   <LI>Untreated pediatric primitive neuroectodermal tumor in vivo: 
Quantitation of taurine with MR spectroscopy<BR> 
Kovanlikaya, A; Panigrahy, A; Krieger, MD; Gonzalez-Gomez, I; Ghugre, N; 
McComb, JG; Gilles, FH; Nelson, MD; Bluml, S<BR> 
<I>Radiology</I> <STRONG>236</STRONG>, 1020-1025 (2005).</LI>
<BR>
<BR>

   <LI>Serial proton spectroscopy in a case of adult-onset subacute sclerosing 
panencephalitis<BR> 
Michael, N; Erfurth, A; Ludemann, P; Schuierer, G; Moller, HE<BR> 
<I>Psychiatry Res Neuroimaging</I> <STRONG>139</STRONG>, 269-273 (2005).</LI>
<BR>
<BR>

   <LI>Sex differences in N-acetylaspartate correlates of general 
intelligence: An H-1-MRS study of normal human brain<BR> 
Jung, RE; Haier, RJ; Yeo, RA; Rowland, LM; Petropoulos, H; Levine, AS; 
Sibbitt, WL; Brooks, WM<BR> 
<I>NeuroImage</I> <STRONG>26</STRONG>, 965-972 (2005).</LI>
<BR>
<BR>

   <LI>Detection of subclinical and overt hepatic encephalopathy and treatment 
control after L-ornithine-L-aspartate medication by magnetic resonance 
spectroscopy (H-1-MRS)<BR> 
Hass, HG; Nagele, T; Seeger, U; Hosl, F; Gregor, M; Kaiser, S<BR> 
<I>Z Gastroenterologie</I> <STRONG>43</STRONG>, 373-378 (2005).</LI>
<BR>
<BR>

   <LI>Late proton MR spectroscopy in children after traumatic brain injury: 
Correlation with cognitive outcomes<BR> 
Hunter, JV; Thornton, RJ; Wang, ZJ; Levin, HS; Roberson, G; Brooks, WM; Swank, 
PR<BR> 
<I>Amer J Neuroradiology</I> <STRONG>26</STRONG>, 482-488 (2005).</LI>
<BR>
<BR>

   <LI>A proton magnetic resonance spectroscopy investigation of the 
dorsolateral prefrontal cortex in acute mania<BR> 
Frey, BN; Folgierini, M; Nicoletti, M; Machado-Vieira, R; Stanley, JA; Soares, 
JC; Kapczinski, F<BR> 
<I>Human Psychopharmacology Clin Exper</I> <STRONG>20</STRONG>, 133-139 
(2005).</LI>
<BR>
<BR>

   <LI>Brain glutamine by MRS in a patient with urea cycle disorder and 
coma<BR> 
Kojic, J; Robertson, PL; Quint, DJ; Martin, DM; Pang, YX; Sundgren, PC<BR> 
<I>Pediatric Neurology</I> <STRONG>32</STRONG>, 143-146 (2005).</LI>
<BR>
<BR>

   <LI>Evidence for glutamatergic neuronal dysfunction in the prefrontal 
cortex in chronic but not in first-episode patients with schizophrenia: a 
proton magnetic resonance spectroscopy study<BR> 
Ohrmann, P; Siegmund, A; Suslow, T; Spitzberg, K; Kersting, A; Arolt, V; 
Heindel, W; Pfleiderer, B<BR> 
<I>Schizophrenia Res</I> <STRONG>73</STRONG>, 153-157 (2005).</LI>
<BR>
<BR>

   <LI>Quantitative single-voxel spectroscopy: The reciprocity principle for 
receive-only head coils<BR> 
Jost, G; Harting, I; Heiland, S<BR> 
<I>J Magn Reson Imaging</I> <STRONG>21</STRONG>, 66-71 (2005).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopic imaging in brain tumor 
diagnosis<BR> 
Gruber, S; Stadlbauer, A; Mlynarik, V; Gatterbauer, B; Roessler, K; Moser, 
E<BR> 
<I>Neurosurgery Clinics N Amer</I> <STRONG>16</STRONG>, 101+ (2005).</LI>
<BR>
<BR>

   <LI>Optimized diffusion-weighted spectroscopy for measuring brain glutamate 
apparent diffusion coefficient on a whole-body MR system<BR> 
Valette, J; Guillermier, M; Besret, L; Boumezbeur, F; Hantraye, P; Lebon, V<BR>
<I>NMR Biomed</I> <STRONG>18</STRONG>, 527-533 (2005).</LI>
<BR>
<BR>

   <LI>Magnetization transfer effect on human brain metabolites and 
macromolecules<BR> 
McLean, MA; Simister, RJ; Barker, GJ; Duncan, JS<BR> 
<I>Magn Reson Med</I> <STRONG>54</STRONG>, 1281-1285 (2005).</LI>
<BR>
<BR>

   <LI>Incidence of brain creatine transporter deficiency in males with 
developmental delay referred for brain magnetic resonance imaging<BR> 
Newmeyer, A; Cecil, KM; Schapiro, M; Clark, JF; Degrauw, TJ<BR> 
<I>J Devel Behav Pediatrics</I> <STRONG>26</STRONG>, 276-282 (2005).</LI>
<BR>
<BR>

   <LI>H-1 magnetic resonance spectroscopy of autosomal ataxias<BR> 
Viau, M; Marchand, L; Bard, C; Boulanger, Y<BR> 
<I>Brain Res</I> <STRONG>1049</STRONG>, 191-202 (2005).</LI>
<BR>
<BR>

   <LI>MR relaxometry and 1H MR spectroscopy for the determination of iron and 
metabolite concentrations in PKAN patients<BR> 
Hajek, M; Adamoviova, M; Herynek, V; Skoch, A; Jiru, F; Krepelova, A; 
Dezortova, M<BR> 
<I>Eur Radiology</I> <STRONG>15</STRONG>, 1060-1068 (2005).</LI>
<BR>
<BR>

   <LI>Physiologic variability of single-voxel proton MR spectroscopic 
measurements at 3T<BR> 
Wellard, RM; Briellmann, RS; Jennings, C; Jackson, GD<BR> 
<I>Amer J Neuroradiology</I> <STRONG>26</STRONG>, 585-590 (2005).</LI>
<BR>
<BR>

   <LI>An automated algorithm for combining multivoxel MRS data acquired with 
phased-array coils<BR> 
Maril, N; Lenkinski, RE<BR> 
<I>J Magn Reson Imaging</I> <STRONG>21</STRONG>, 317-322 (2005).</LI>
<BR>
<BR>

   <LI>MRI and proton MR spectroscopy in acute disseminated 
encephalomyelitis<BR> 
Mader, I; Wolff, M; Nagele, T; Niemann, G; Grodd, W; Kuker, W<BR> 
<I>Childs Nervous System</I> <STRONG>21</STRONG>, 566-572 (2005).</LI>
<BR>
<BR>

   <LI>Elevated white matter myo-inositol in clinically isolated syndromes
   suggestive of multiple sclerosis<BR> 
KTM Fernando, MA McLean, DT Chard, DG MacManus, CM Dalton, KA Miszkiel, RM
Gordon, GT Plant, AJ Thompson, DH Miller<BR> 
<I>Brain</I> <STRONG>127</STRONG>, 1361-1369 (2004).</LI>
<BR>
<BR>

   <LI>Highly resolved in vivo <SUP>1</SUP>H NMR spectroscopy of the mouse
   brain at 9.4 T<BR> 
I Tk&#225;c, P-G Henry, P Andersen, CD Keene, WC Low, R Gruetter<BR> 
<I>Magn Reson Med</I> <STRONG>52</STRONG>, 478-484 (2004).</LI>
<BR>
<BR>

   <LI>A comparative study of myo-inositol quantification using LCmodel at 1.5
   T and 3.0 T with 3 D <SUP>1</SUP>H proton spectroscopic imaging of the
   human brain<BR> 
R Srinivasan, D Vigneron, N Sailasuta, R Hurd, S Nelson<BR> 
<I>Magn Reson Imaging</I> <STRONG>22</STRONG>, 523-528 (2004).</LI>
<BR>
<BR>

   <LI>NMR measurement of brain oxidative metabolism in monkeys using
   <SUP>13</SUP>C-labeled glucose without a <SUP>13</SUP>C radiofrequency
   channel<BR> 
F Boumezbeur, L Besret, J Valette, F Vaufrey, P-G Henry, V Slavov, E
Giacomini, P Hantraye, G Bloch, V Lebon<BR> 
<I>Magn Reson Med</I> <STRONG>52</STRONG>, 33-40 (2004).</LI>
<BR>
<BR>

   <LI>Quantitative <SUP>1</SUP>H-MRS of healthy human cortex, hippocampus,
   and thalamus: Metabolite concentrations, quantification precision, and
   reproducibility<BR> 
JJG Geurts, F Barkhof, JA Castelijns, BMJ Uitdehaag, CH Polman, PJW Pouwels<BR>
<I>J Magn Reson Imaging</I> <STRONG>20</STRONG>, 366-371 (2004).</LI>
<BR>
<BR>

   <LI>Proton MRS in acute traumatic brain injury: Role for
   glutamate/glutamine and choline for outcome prediction<BR> 
L Shutter, KA Tong, BA Holshouser<BR> 
<I>J Neurotrauma</I> <STRONG>21</STRONG>, 1693-1705 (2004).</LI>
<BR>
<BR>

   <LI>3-T proton MRS investigation of glutamate and glutamine in adolescents
   at high genetic risk for schizophrenia<BR> 
P Tibbo, C Hanstock, A Valiakalayil, P Allen<BR> 
<I>Am J Psychiatry</I> <STRONG>161</STRONG>, 1116-1118 (2004).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy in succinic semialdehyde dehydrogenase
   deficiency<BR>
T Ethofer, U Seeger, U Klose, M Erb, B Kardatzki, E Kraft, GB Landwehrmeyer, W
Grodd, A Storch<BR> 
<I>Neurology</I> <STRONG>62</STRONG>, 1016-1018 (2004).</LI>
<BR>
<BR>

   <LI>Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats
   assessed by <I>in vivo</I> <SUP>1</SUP>H magnetic resonance spectroscopy<BR>
M van der Graaf, SWJ Janssen, JJA van Asten, ARMM Hermus, CGJ Sweep, JA
Pikkemaat, GJM Martens, A Heerschap<BR> 
<I>NMR Biomed</I> <STRONG>17</STRONG>, 405-410 (2004).</LI>
<BR>
<BR>

   <LI>N-Acetylaspartate levels of left frontal cortex are associated with
   verbal intelligence in women but not in men:  A proton magnetic resonance
   spectroscopy study<BR> 
B Pfleiderer, P Ohrmann, T Suslow, M Wolgast, AL Gerlach, W Heindel, N
Michael<BR> 
<I>Neuroscience</I> <STRONG>123</STRONG>, 1053-1058 (2004).</LI>
<BR>
<BR>

   <LI>MR Imaging and spectroscopic study of epileptogenic hypothalamic
   hamartomas: Analysis of 72 cases<BR> 
JL Freeman, LT Coleman, RM Wellard, MJ Kean, JV Rosenfeld, GD Jackson, SF
Berkovic, AS Harvey<BR> 
<I>Am J Neuroradiol</I> <STRONG>25</STRONG>, 450-462 (2004).</LI>
<BR>
<BR>

   <LI>Brain metabolic alterations in medication-free patients with bipolar
   disorder<BR>
SR Dager, SD Friedman, A Parow, C Demopulos, AL Stoll, IK Lyoo, DL Dunner, PF
Renshaw<BR>
<I>Arch Gen Psychiatry</I> <STRONG>61</STRONG>, 450-458 (2004).</LI>
<BR>
<BR>

   <LI>Differentiation of metastases from high-grade gliomas using short echo
   time <SUP>1</SUP>H spectroscopy<BR> 
KS Opstad, MM Murphy, PR Wilkins, BA Bell, JR Griffiths, FA Howe<BR> 
<I>J Magn Reson Imaging</I> <STRONG>20</STRONG>, 187-192 (2004).</LI>
<BR>
<BR>

   <LI>Guanidinoacetate methyltransferase deficiency: Differences of creatine
   uptake in human brain and muscle<BR> 
R Ensenauer, T Thiel, KO Schwab, U Tacke, S St&ouml;ckler-Ipsiroglu, A
Schulze, J Hennig, W Lehnert<BR> 
<I>Mol Genet Metab</I> <STRONG>82</STRONG>, 208-213 (2004).</LI>
<BR>
<BR>

   <LI>Quantitation of simulated short echo time <SUP>1</SUP>H human brain
   spectra by LCModel and AMARES<BR> 
M Kanowski, J Kaufmann, J Braun, J Bernarding, C Tempelmann<BR> 
<I>Magn Reson Med</I> <STRONG>51</STRONG>, 904-912 (2004).</LI>
<BR>
<BR>

   <LI>MR imaging and spectroscopy in juvenile Huntington disease<BR> 
M Schapiro, KM Cecil, J Doescher, AM Kiefer, BV Jones<BR> 
<I>Pediatr Radiol</I> <STRONG>34</STRONG>, 640-643 (2004).</LI>
<BR>
<BR>

   <LI>Cerebral creatine kinase deficiency influences metabolite levels and
   morphology in the mouse brain: A quantitative <I>in vivo</I> <SUP>1</SUP>H
   and <SUP>31</SUP>P magnetic resonance study<BR> 
HJA in 't Zandt, WKJ Renema, F Streijger, C Jost, DWJ Klomp, F Oerlemans, CEEM
Van der Zee, B Wieringa, A Heerschap<BR> 
<I>J Neurochem</I> <STRONG>90</STRONG>, 1321-1330 (2004).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy detected glutamate/glutamine is increased in
   children with traumatic brain injury<BR> 
S Ashwal, B Holshouser, K Tong, T Serna, R Osterdock, M Gross, D Kido<BR> 
<I>J Neurotrauma</I> <STRONG>21</STRONG>, 1539-1552 (2004).</LI>
<BR>
<BR>

   <LI>In vivo <SUP>1</SUP>H magnetic resonance spectroscopy of rat brain
   after valproate administration<BR> 
J Leib, J Braun, A Schilling, C Klingner, S Seyfert, W Vollmann, E Gedat, J
Bernarding<BR>
<I>Neuroradiology</I> <STRONG>46</STRONG>, 363-367 (2004).</LI>
<BR>
<BR>

   <LI>Longitudinal study of MRS metabolites in Rasmussen encephalitis<BR> 
RM Wellard, RS Briellmann, JC Wilson, RM Kalnins, DP Anderson, P Federico, GCA
Fabinyi, IE Scheffer, AS Harvey, GD Jackson<BR> 
<I>Brain</I> <STRONG>127</STRONG>, 1302-1312 (2004).</LI>
<BR>
<BR>

   <LI>Hepatitis C virus infection is associated with reduced white matter
   N-acetylaspartate in abstinent methamphetamine users<BR> 
MJ Taylor, SL Letendre, BC Schweinsburg, OM Alhassoon, GG Brown, A Gongvatana,
I Grant<BR> 
<I>J Internat Neuropsychol Soc</I> <STRONG>10</STRONG>, 110-113 (2004).</LI>
<BR>
<BR>

   <LI>Discrimination between neurochemical and macromolecular signals in
   human frontal lobes using short echo time proton magnetic resonance
   spectroscopy<BR> 
MA McLean, RJ Simister, GJ Barker, JS Duncan<BR> 
<I>Faraday Discuss</I> <STRONG>126</STRONG>, 93-102 (2004).</LI>
<BR>
<BR>

   <LI>MR imaging and proton MR spectroscopic studies in Sj&ouml;gren-Larsson
   syndrome: Characterization of the leukoencephalopathy<BR> 
MAAP Willemsen, M van der Graaf, MS van der Knaap, A Heerschap, PHMF van
Domburg, FJM Gabre&euml;ls, JJ Rotteveel<BR> 
<I>Am J Neuroradiol</I> <STRONG>25</STRONG>, 649-657 (2004).</LI>
<BR>
<BR>

   <LI>Lithium and valproic acid treatment effects on brain chemistry in
   bipolar disorder<BR> 
SD Friedman, SR Dager, A Parow, F Hirashima, C Demopulos, AL Stoll, IK Lyoo,
DL Dunner, PF Renshaw<BR> 
<I>Biol Psychiatry</I> <STRONG>56</STRONG>, 340-348 (2004).</LI>
<BR>
<BR>

   <LI>Altered neurometabolite development in HIV-infected
   children. Correlation with neuropsychological tests<BR> 
MA Keller, TN Venkatraman, A Thomas, A Deveikis, C LoPresti, J Hayes,
N. Berman, I Walot, S Padilla, J Johnston-Jones, T Ernst, L Chang<BR> 
<I>Neurology</I> <STRONG>62</STRONG>, 1810-1817 (2004).</LI>
<BR>
<BR>

   <LI>Severe hypomyelination associated with increased levels of
   N-acetylaspartylglutamate in CSF<BR> 
NI Wolf, MAAP Willemsen, UF Engelke, MS van der Knaap, PJW Pouwels, I Harting,
J Zschocke, EA Sistermans, D Rating, RA Wevers<BR> 
<I>Neurology</I> <STRONG>62</STRONG>, 1503-1508 (2004).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> <SUP>13</SUP>C NMR measurement of activity-dependent
   malate-aspartate shuttle flux in the brain<BR> 
P-G Henry, K Ugurbil, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 27 (2004).</LI>
<BR>
<BR>

   <LI>Neurochemical profile of the hibernating ground squirrel measured by
   <SUP>1</SUP>H NMR spectroscopy<BR> 
P-G Henry, KP Russeth, I Tkac, LR Drewes, MT Andrews, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 30 (2004).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> CSI of glutamate in the monkey brain<BR> 
C Juchem, H Merkle, NG Logothetis, J Pfeuffer<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 32 (2004).</LI>
<BR>
<BR>

   <LI>Eicosapentanoic acid supplementation alters <SUP>1</SUP>H MRS
   metabolite profiles in first episode psychosis<BR> 
R Wellard, SJ Wood, M McConchie, GD Jackson, D Velakoulis, PD McGorry, C
Pantelis, GE Berger<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 106 (2004).</LI>
<BR>
<BR>

   <LI>Subclinical hepatic encephalopathy in children studied by in vivo
   <SUP>1</SUP>H NMR spectroscopy at 4 Tesla<BR> 
I Tkac, HR Hamernick, S Weisdorf-Schindle, G Oz, P-G Henry, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 107 (2004).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy of substantia nigra in the human brain at 4
   Tesla: Measurement of high GABA concentrations<BR> 
G Oz, PJ Tuite, M Terpstra, I Tkac, P Aia, J Lowary, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 110 (2004).</LI>
<BR>
<BR>

   <LI>Measurement of glutamate ADC in the monkey brain using an optimized
   diffusion-weighted STEAM sequence at 3T<BR> 
J Valette, L Besret, F Boumezbeur, P Hantraye, G Bloch, V Lebon<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 258 (2004).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H-MRS detects brain metabolite changes associated with
   early onset type-1 diabetes<BR> 
RM Wellard, D Rankins, G Jackson, G Werther, E Northam<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 292 (2004).</LI>
<BR>
<BR>

   <LI>Quantitative 2-D proton spectroscopic imaging in children following
   traumatic brain injury<BR> 
RJ Thornton, ZJ Wang, HS Levin, WM Brooks, PR Swank, JV Hunter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 294 (2004).</LI>
<BR>
<BR>

   <LI>Short TE proton MRS in acute and treated Graves' disease<BR> 
ER Danielsen, T Elberling, AK Rasmussen, G Waldemar, U Feldt-Rasmussen, C
Thomsen<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 298 (2004).</LI>
<BR>
<BR>

   <LI>Measurement of brain oxidative metabolism in monkeys using
   <SUP>1</SUP>H-NMR spectroscopy without <SUP>13</SUP>C editing and
   decoupling<BR>
F Boumezbeur, L Besret, J Valette, F Vaufrey, P-G Henry, V Slavov, E 
Giacomini, P Hantraye, G Bloch, V Lebon<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 300 (2004).</LI>
<BR>
<BR>

   <LI>Unearthing tiny signals in <SUP>1</SUP>H NMR spectra from the human
   brain: Measurement of Vitamin C and phosphomono and diesters in vivo<BR> 
M Terpstra, P-G Henry, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 309 (2004).</LI>
<BR>
<BR>

   <LI>MRS shows glial increase but no neuro-axonal damage in MS NAWM<BR> 
H Vrenken, F Barkhof, J Castelijns, C Polman, P Pouwels<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 466 (2004).</LI>
<BR>
<BR>

   <LI>Evidence of elevated glutamate and glial activity in multiple sclerosis
   using TE-averaged spectroscopy at 3T<BR> 
R Srinivasan, N Sailasuta, R Hurd, S Nelson, D Pelletier<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 467 (2004).</LI>
<BR>
<BR>

   <LI>Prefrontal N-acetylaspartate:creatine ratio predicts functional outcome
   eighteen months after a first psychotic episode<BR> 
SJ Wood, G Berger, D Velakoulis, P Conus, GW Stuart, M Lambert, PD McGorry, P
Desmond, C Pantelis<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 522 (2004).</LI>
<BR>
<BR>

   <LI>TE averaged PRESS: A better tool for diagnosing early Alzheimer's
   disease?<BR> 
I Hancu, E Zimmerman, T O'Keefe, N Sailasuta, R Hurd<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 527 (2004).</LI>
<BR>
<BR>

   <LI>Automated classification of <SUP>1</SUP>H MRS brain tumor spectra: A
   linear discriminant analysis comparison of LCModel quantification versus
   complete spectra<BR> 
KS Opstad, C Ladroue, JR Griffiths, FA Howe<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 609 (2004).</LI>
<BR>
<BR>

   <LI>Quantitative 1H MRS and diffusion MRI of untreated pediatric primitive
   neuroectodermal tumors<BR> 
NR Ghugre, A Panigrahy, A Kovanlikaya, I Gonzales, M Krieger, MD Nelson, S
Bluml<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 614 (2004).</LI>
<BR>
<BR>

   <LI>Correlation between T2-relaxometry and proton MRS abnormalities in
   different epilepsy syndromes<BR> 
RS Briellmann, RM Wellard, GS Pell, AB Waites, GD Jackson<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1330 (2004).</LI>
<BR>
<BR>
   <LI>In vivo MR assessment of hippocampal volume and neurochemical changes in
   rats with altered corticosteroid milieu<BR> 
MI Schubert, R Kalisch, I Sotiropoulos, C Catania, OF Almeida, N Sousa, DP
Auer<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1445 (2004).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopic characterization of Alzheimer's disease,
   fronto-temporal type of dementia and progressive supranuclear palsy by a
   3.0 Tesla system<BR> 
M Mihara, N Hattori, K Abe, M Umeda, N Inoue, Y Someya, M Matsui, S Sakoda, T
Sawada<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1478 (2004).</LI>
<BR>
<BR>
   <LI>Niacin insensitivity is related to <SUP>1</SUP>H MRS abnormalities in
   drug-naive first episode psychosis<BR> 
SJ Wood, G Berger, M McConchie, RM Wellard, D Velakoulis, PD McGorry, G
Jackson, C Pantelis<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1484 (2004).</LI>
<BR>
<BR>

   <LI>Comparison of glutathione (GSH) concentrations quantified with STEAM
   versus edited spectroscopy: Application to schizophrenia<BR> 
M Terpstra, SC Schulz, JT Vaughan, K Ugurbil, KO Lim, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1485 (2004).</LI>
<BR>
<BR>

   <LI>Metabolite T<SUB>1</SUB> relaxation is preserved in large multiple
   sclerosis lesions<BR> 
C Laule, EE Brief, IM Vavasour, AL Traboulsee, DK Li, AL MacKay<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1507 (2004).</LI>
<BR>
<BR>

   <LI>Interrelation between MR based surrogate markers of multiple sclerosis,
   disease severity and altered neuroendocrinological functioning<BR> 
EM Schumann, T K&uuml;mpfel, T Schirmer, M Blazevic, J Behrends, A
Wism&uuml;ller, C Trenkwalder, DP Auer<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1509 (2004).</LI>
<BR>
<BR>

   <LI>Brain creatine deficiency treatment: Long term brain 1H and 31P MRS
   monitoring study under different creatine regimen<BR> 
M Bianchi, M Tosetti, V Leuzzi, R Battini, M Alessandri, G Cioni<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1619 (2004).</LI>
<BR>
<BR>

   <LI>Proton spectra in aged rats: Correlation with learning abilities<BR> 
D Jirak, K Namestkova, M Burian, I Vorisek, E Sykova, M Hajek<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2038 (2004).</LI>
<BR>
<BR>

   <LI>Improved preoperative diagnostics of brain tumors by quantification of
   1H-MRSI metabolites<BR> 
A Stadlbauer, O Ganslandt, S Gruber, C Nimsky, R Buslei, R Fahlbusch, E
Moser<BR>
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2053 (2004).</LI>
<BR>
<BR>

   <LI>An LCModel-based automatic software tool for the reconstruction of
   anatomically- and pathologically-matched voxels using high-resolution
   3D-spectroscopic imaging: Applications in tumour patients<BR> 
S Gruber, A Stadlbauer, V Mlynarik, O Ganslandt, E Moser<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2078 (2004).</LI>
<BR>
<BR>

   <LI>Glutamate/glutamine complex, myoinositol and lipid in late
   radiation-induced injury of the brain: An in vivo 1H MRS study<BR> 
Y Chan, D Yeung, S Leung, F Lee<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2079 (2004).</LI>
<BR>
<BR>

   <LI>An automated algorithm for combining multivoxel MRS data acquired with
   multicoils<BR> 
N Maril, RE Lenkinski<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2136 (2004).</LI>
<BR>
<BR>

   <LI>An approach for absolute quantification of single voxel MR spectroscopy
   with receive-only head coils<BR> 
G Jost, I Harting, S Heiland<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2257 (2004).</LI>
<BR>
<BR>

   <LI>Simple absolute signal scaling for spectroscopic data acquired with
   phased-array coils at 1.5T<BR> 
T Schirmer, S Kohler, D Gultekin, T Raidy<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2259 (2004).</LI>
<BR>
<BR>

   <LI>Evaluation of the effects of aging and gender differences on the
   concentrations of cerebral metabolites by general linear model analysis<BR> 
N Hattori, M Mihara, K Abe, M Umeda, M Fukunaga, Y Someya, M Matsui, S Sakoda,
T Sawada<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2262 (2004).</LI>
<BR>
<BR>

   <LI>Phosphocreatine and neurotransmitters changes in the newborn rat during
   acute hypoglycemia measured by <I>in vivo</I> <SUP>1</SUP>H NMR
   spectroscopy<BR> 
I Tkac, R Rao, AT Basford, MK Georgieff, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2275 (2004).</LI>
<BR>
<BR>

   <LI>The neurochemistry of cortical auditory processing: Insights from
   magnetic resonance spectroscopy and magnetoencephalography<BR> 
P S&ouml;r&ouml;s, N Michael, M Tollk&ouml;tter, B Pfleiderer<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2282 (2004).</LI>
<BR>
<BR>

   <LI>Quantitative determination of postmortem intervals: in situ
   <SUP>1</SUP>H-MR spectroscopy of human brain compared to traditional
   forensic methods<BR> 
E Scheurer, M Ith, K Yen, M Thali, P Vermathen, R Kreis, R Dirnhofer, C 
Boesch<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2283 (2004).</LI>
<BR>
<BR>

   <LI>Clues for the differentiation between autolytic and bacterial products
   in decomposing brain<BR> 
M Ith, M Thali, E Scheurer, R Kreis, R Dirnhofer, C Boesch<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2284 (2004).</LI>
<BR>
<BR>

   <LI>A novel approach for reducing chemical shift registration error at 3T:
   Short TE CPRESS<BR> 
N Sailasuta, RE Hurd, C Cunningham, D Vigneron, S Nelson J Pauly<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2297 (2004).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy (1H-MRS) of tibialis anterior
   muscle: Intra-individual variation of metabolite ratios in healthy
   volunteers<BR> 
M Torriani, BJ Thomas, ME Jensen, EF Halpern, WE Palmer, DI Rosenthal<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2400 (2004).</LI>
<BR>
<BR>

   <LI>Functional proton magnetic resonance spectroscopy of the human primary
   visual cortex: Metabolite and neurotransmitter concentrations<BR> 
R Katz-Brull, DC Alsop, RP Marquis, RE Lenkinski<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2426 (2004).</LI>
<BR>
<BR>

   <LI>Magnetization transfer spectroscopy of metabolites and macromolecules
   in human brain in vivo<BR> 
MA McLean, RJ Simister, GJ Barker, JS Duncan<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2428 (2004).</LI>
<BR>
<BR>

   <LI>Improving sensitivity of MRS by motion-related error correction in
   patients with Huntington's disease<BR> 
Y Kuznetsov, Y Boulanger<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2446 (2004).</LI>
<BR>
<BR>

   <LI>1H MRS study of acute lorazepam in healthy human brain<BR> 
P Davanzo, J O'Neill, T Belin, T Oshiro, V Nikore, JR Alger, M Thomas<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2447 (2004).</LI>
<BR>
<BR>

   <LI>Propylene glycol is essential in the LCModel basis set for paediatric
   brain <SUP>1</SUP>H-MRS<BR> 
W Oakden, MD Noseworthy<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2456 (2004).</LI>
<BR>
<BR>

   <LI>Acute leukoencephalopathy after inhalation of a single dose of 
heroin.<BR> 
S Vella, R Kreis, KO Lovblad, M Steinlin<BR> 
<I>Neuropediatrics</I> <STRONG>34</STRONG>, 100-104 (2003).</LI>
<BR>
<BR>

   <LI>Toward dynamic isotopomer analysis in rat brain <I>in vivo</I>:
   automatic quantitation of <SUP>13</SUP>C NMR spectra using LCModel.<BR> 
P-G Henry, G &Ouml;z, S Provencher, R Gruetter<BR> 
<I>NMR Biomed</I> <STRONG>16</STRONG>, 400-412 (2003).</LI>
<BR>
<BR>

   <LI>Quantitative proton magnetic resonance spectroscopy of children with
   adrenoleukodystrophy before and after hematopoietic stem cell
   transplantation.<BR> 
B Wilken, P Dechent, K Brockmann, J Finsterbusch, M Baumann, W Ebell, GC
Korenke, PJW Pouwels, FA Hanefeld, J Frahm<BR> 
<I>Neuropediatrics</I> <STRONG>34</STRONG>, 237-246 (2003).</LI>
<BR>
<BR>

   <LI>Quantification of metabolic differences in the frontal brain of
   depressive patients and controls obtained by <SUP>1</SUP>H-MRS at 3 
Tesla.<BR> 
S Gruber, R Frey, V Mlyn&#225;rik, A Stadlbauer, A Heiden, S Kasper, GJ Kemp,
E Moser<BR> 
<I>Invest Radiol</I> <STRONG>38</STRONG>, 403-408 (2003).</LI>
<BR>
<BR>

   <LI>Measurement of reduced glutathione (GSH) in human brain using LCModel
   analysis of difference-edited spectra.<BR> 
M Terpstra, P-G Henry, Rolf Gruetter<BR> 
<I>Magn Reson Med</I> <STRONG>50</STRONG>, 19-23 (2003).</LI>
<BR>
<BR>

   <LI>Brain metabolism in Alzheimer disease and vascular dementia assessed by
   in vivo proton magnetic resonance spectroscopy.<BR> 
S Herminghaus, L Fr&ouml;lich, C Gorriz, U Pilatus, T Dierks, H-J Wittsack, H
Lanfermann, K Maurer, FE Zanella<BR> 
<I>Psychiatry Res: Neuroimaging</I> <STRONG>123</STRONG>, 183-190 (2003).</LI>
<BR>
<BR>

   <LI>Developmental and regional changes in the neurochemical profile of the
   rat determined by in vivo <SUP>1</SUP>H NMR spectroscopy.<BR> 
I Tk&#225;c, R Rao, MK Georgieff, R Gruetter<BR> 
<I>Magn Reson Med</I> <STRONG>50</STRONG>, 24-32 (2003).</LI>
<BR>
<BR>

   <LI>Effective electroconvulsive therapy reverses glutamate/glutamine
   deficit in the left anterior cingulum of unipolar depressed patients.<BR> 
B Pfleiderer, N Michael, A Erfurth, P Ohrmann, U Hohmann, M Wolgast, M
Fiebich, V Arolt, W Heindel<BR> 
<I>Psychiatry Res: Neuroimaging</I> <STRONG>122</STRONG>, 185-192 (2003).</LI>
<BR>
<BR>

   <LI>Proton MRS profile of cerebral metabolic abnormalities in Krabbe
   disease.<BR>
K Brockmann, P Dechent, B Wilken, O Rusch, J Frahm, F Hanefeld<BR> 
<I>Neurology</I> <STRONG>60</STRONG>, 819-825 (2003).</LI>
<BR>
<BR>

   <LI>Hippocampal regional asymmetry assessed by <SUP>1</SUP>H-MRS in
   rolandic epilepsy.<BR> 
S Lundberg, J Weis, O Eeg-Olofsson, R Raininko<BR> 
<I>Epilepsia</I> <STRONG>44</STRONG>, 205-210 (2003).</LI>
<BR>
<BR>

   <LI>Metabolic changes after repetitive transcranial magnetic stimulation
   (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic
   resonance spectroscopy (<SUP>1</SUP>H MRS) study of healthy brain.<BR> 
N Michael, M G&ouml;sling, M Reutemann, A Kersting, W Heindel, V Arolt, B
Pfleiderer<BR>
<I>Eur J Neurosci</I> <STRONG>17</STRONG>, 2462-2468 (2003).</LI>
<BR>
<BR>

   <LI>Cerebral proton magnetic resonance spectroscopy in infantile Alexander
   disease.<BR>
K Brockmann, P Dechent, M Meins, M Haupt, J Sperner, U Stephani, J Frahm, F
Hanefeld<BR>
<I>J Neurol</I> <STRONG>250</STRONG>, 300-306 (2003).</LI>
<BR>
<BR>

   <LI>Perinatal iron deficiency alters the neurochemical profile of the
   developing rat hippocampus.<BR> 
R Rao, I Tkac, EL Townsend, R Gruetter, MK Georgieff<BR> 
<I>J Nutr</I> <STRONG>133</STRONG>, 3215-3221 (2003).</LI>
<BR>
<BR>

   <LI>Neurotrophic effects of electroconvulsive therapy: A proton magnetic
   resonance study of the left amygdalar region in patients with
   treatment-resistant depression.<BR> 
N Michael, A Erfurth, P Ohrmann, V Arolt, W Heindel, B Pfleiderer<BR> 
<I>Neuropsychopharmacology</I> <STRONG>28</STRONG>, 720-725 (2003).</LI>
<BR>
<BR>

   <LI>Metabolic changes in the vicinity of brain contusions: A proton
   magnetic resonance spectroscopy and histology study.<BR> 
MU Schuhmann, D Stiller, M Skardelly, J Bernarding, PM Klinge, A Samii, M
Samii, T Brinker<BR> 
<I>J Neurotrauma</I> <STRONG>20</STRONG>, 725-743 (2003).</LI>
<BR>
<BR>

   <LI>Metabolic changes within the left dorsolateral prefrontal cortex
   occurring with electroconvulsive therapy in patients with treatment
   resistant unipolar depression.<BR> 
N Michael, A Erfurth, P Ohrmann, V Arolt, W Heindel, B Pfleiderer<BR> 
<I>Psychological Med</I> <STRONG>33</STRONG>, 1277-1284 (2003).</LI>
<BR>
<BR>

   <LI>Parameterized evaluation of macromolecules and lipids in proton MR
   spectroscopy of brain diseases.<BR> 
U Seeger, U Klose, I Mader, W Grodd, T N&auml;gele<BR> 
<I>Magn Reson Med</I> <STRONG>49</STRONG>, 19-28 (2003).</LI>
<BR>
<BR>

   <LI>Magnetic resonance proton spectroscopy and diffusion weighted imaging
   of chick embryo brain in ovo.<BR> 
DM Peebles, JC Dixon, JS Thornton, EB Cady, A Priest, SL Miller, CE Blanco, TL
Mulder, RJ Ordidge, CH Rodeck<BR> 
<I>Developmental Brain Res</I> <STRONG>141</STRONG>, 101-107 (2003).</LI>
<BR>
<BR>

   <LI>MR imaging and spectroscopy of a tuber cinereum harmartoma in a patient
   with growth hormone deficiency and hypogonadotropic hypogonadism.<BR> 
DD Martin, U Seeger, MB Ranke, W Grodd<BR> 
<I>Am J Neuroradiol</I> <STRONG>24</STRONG>, 1177-1180 (2003).</LI>
<BR>
<BR>

   <LI>Acute mania is accompanied by elevated glutamate/glutamine levels
   within the left dorsolateral prefrontal cortex.<BR> 
N Michael, A Erfurth, P Ohrmann, M G&ouml;ssling, V Arolt, W Heindel, B
   Pfleiderer<BR> 
<I>Psychopharmacology</I> <STRONG>168</STRONG>, 344-346 (2003).</LI>
<BR>
<BR>

   <LI>Characterization of oligodendrogliomas using short echo time
   <SUP>1</SUP>H MR spectroscopic imaging.<BR> 
M Rijpkema, J Schuuring, Y van der Meulen, M van der Graaf, H Bernsen, R
Boerman, A van der Kogel, A Heerschap<BR> 
<I>NMR Biomed</I> <STRONG>16</STRONG>, 12-18 (2003).</LI>
<BR>
<BR>

   <LI>Myoinositol abnormalities in temporal lobe epilepsy.<BR> 
RM Wellard, RS Briellmann, JW Prichard, A Syngeniotis, GD Jackson<BR>
<I>Epilepsia</I> <STRONG>44</STRONG>, 815-821 (2003).</LI>
<BR>
<BR>

   <LI>Reduced myo-inositol and total choline measured with cerebral MRS in
   acute thyrotoxic Graves' disease.<BR>
TV Elberling, ER Danielsen, &#197;K Rasmussen, U Feldt-Rasmussen, G Waldemar, C
Thomsen<BR> 
<I>Neurology</I> <STRONG>60</STRONG>, 142-145 (2003).</LI>
<BR>
<BR>

   <LI>Safety aspects of chronic low-frequency transcranial magnetic
   stimulation based on localized proton magnetic resonance spectroscopy and
   histology of the rat brain.<BR> 
D Liebetanz, S Fauser, T Michaelis, B Cz&#233;h, T Watanabe, W Paulus, J
Frahm, E Fuchs<BR> 
<I>J Psychiatric Res</I> <STRONG>37</STRONG>, 277-286 (2003).</LI>
<BR>
<BR>

   <LI>Detection of elevated glutathione in meningiomas by quantitative in vivo
   <SUP>1</SUP>H MRS.<BR> 
KS Opstad, SW Provencher, BA Bell, JR Griffiths, FA Howe<BR> 
<I>Magn Reson Med</I> <STRONG>49</STRONG>, 632-637 (2003).</LI>
<BR>
<BR>

   <LI>Regional brain chemical alterations in young children with autism
   spectrum disorder.<BR> 
SD Friedman, DW Shaw, AA Artru, TL Richards, J Gardner, G Dawson, S Posse, SR
Dager<BR> 
<I>Neurology</I> <STRONG>60</STRONG>, 100-107 (2003).</LI>
<BR>
<BR>

   <LI>Hippocampal <I>N</I>-acetyl aspartate levels do not mirror neuronal
   cell densities in creatine-supplemented epileptic rats.<BR> 
S Vielhaber, AP Kudin, TA Kudina, D Stiller, H Scheich, A Schoenfeld, H
Feistner, H-J Heinze, CE Elger, WS Kunz<BR> 
<I>Eur J Neurosci</I> <STRONG>18</STRONG>, 2292-2300 (2003).</LI>
<BR>
<BR>

   <LI>A new leukoencephalopathy with brainstem and spinal cord involvement
   and high lactate.<BR> 
MS van der Knaap, P van der Voorn, F Barkhof, R Van Coster, I
Kr&auml;geloh-Mann, A Feigenbaum, S Blaser, JSH Vles, P Rieckmann, PJW
Pouwels<BR>
<I>Ann Neurol</I> <STRONG>53</STRONG>, 252-258 (2003).</LI>
<BR>
<BR>

   <LI>Comparison of longitudinal metabolite relaxation times in different
   regions of human brain at 1.5 and 3 Tesla.<BR> 
T Ethofer, I Mader, U Seeger, G Helms, M Erb, W Grodd, A Ludolph, U Klose<BR> 
<I>Magn Reson Med</I> <STRONG>50</STRONG>, 1296-1301 (2003).</LI>
<BR>
<BR>

   <LI>Localized proton MRS of cerebral metabolite profiles in different mouse
   strains.<BR> 
A Schwarcz, O Natt, T Watanabe, S Boretius, J Frahm, T Michaelis<BR> 
<I>Magn Reson Med</I> <STRONG>49</STRONG>, 822-827 (2003).</LI>
<BR>
<BR>

   <LI>MR spectroscopy of muscle and brain in guanidinoacetate
   methyltransferase (GAMT)-deficient mice: Validation of an animal model to
   study creatine deficiency.<BR> 
WKJ Renema, A Schmidt, JJA van Asten, F Oerlemans, K Ullrich, B Wieringa, D
Isbrandt, A Heerschap<BR> 
<I>Magn Reson Med</I> <STRONG>50</STRONG>, 936-943 (2003).</LI>
<BR>
<BR>

   <LI>Is myo-inositol a measure of glial swelling after stroke?  A magnetic
   resonance study.<BR> 
H Rumpel, WEH Lim, HM Chang, LL Chan, GL Ho, MC Wong, KP Tan<BR>
<I>J Magn Reson Imaging</I> <STRONG>17</STRONG>, 11-19 (2003).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy of bipolar disorder versus
   intermittent explosive disorder in children and adolescents.<BR> 
P Davanzo, K Yue, MA Thomas, T Belin, J Mintz, TN Venkatraman, E Santoro, S
Barnett, J McCracken<BR> 
<I>Am J Psychiatry</I> <STRONG>160</STRONG>, 1442-1452 (2003).</LI>
<BR>
<BR>

   <LI>Lower levels of <I>N</I>-acetylaspartate in multiple sclerosis patients
   with the apolipoprotein E epsilon-4 allele.<BR> 
C Enzinger, S Ropele, S Strasser-Fuchs, P Kapeller, H Schmidt, B Poltrum, R
Schmidt, H-P Hartung, F Fazekas<BR> 
<I>Arch Neurol</I> <STRONG>60</STRONG>, 65-70 (2003).</LI>
<BR>
<BR>

   <LI>Proton echo-planar spectroscopic imaging with highly effective outer
   volume suppression using combined presaturation and spatially selective
   echo dephasing.<BR> 
A Chu, JR Alger, GJ Moore, S Posse<BR> 
<I>Magn Reson Med</I> <STRONG>49</STRONG>, 817-821 (2003).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H MR spectroscopy of mesial temporal lobe epilepsies
   treated with Gamma knife.<BR> 
M H&#225;jek, M Dezortov&#225;, R Lisc&#225;k, J Vymazal, V Vladyka<BR> 
<I>Eur Radiol</I> <STRONG>13</STRONG>, 994-1000 (2003).</LI>
<BR>
<BR>

   <LI>Magnetic resonance spectroscopy of cerebral cortex is normal in
   hereditary hyperekplexia due to mutations in the GLRA1 gene.<BR> 
MAJ Tijssen, P Brown, D MacManus, MA McLean, C Davie<BR> 
<I>Mov Disord</I> <STRONG>18</STRONG>, 1538-1541 (2003).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy in first episode psychosis and
   ultra high-risk individuals.<BR> 
SJ Wood, G Berger, D Velakoulis, LJ Phillips, PD McGorry, AR Yung, P Desmond,
C Pantelis<BR> 
<I>Schizophrenia Bull</I> <STRONG>29</STRONG>, 831-843 (2003).</LI>
<BR>
<BR>

   <LI>Effects of alcoholism and gender on brain metabolism.<BR> 
BC Schweinsburg, OM Alhassoon, MJ Taylor, R Gonzalez, JS Videen, GC Brown, TL
Patterson, I Grant<BR> 
<I>Am J Psychiatry</I> <STRONG>160</STRONG>, 1180-1183 (2003).</LI>
<BR>
<BR>

   <LI>T2-based segmentation of periventricular volumes for quantification of
   proton magnetic resonance spectra of multiple sclerosis lesions.<BR> 
G Helms<BR> 
<I>MAGMA</I> <STRONG>16</STRONG>, 10-16 (2003).</LI>
<BR>
<BR>

   <LI>Differences in fMRI and MRS in a monozygotic twin pair discordant for
   schizophrenia (case report).<BR> 
F Spaniel, T H&#225;jek, J Tintera, P Harantov&#225;, M Dezortov&#225;, M
H&#225;jek<BR> 
<I>Acta Psychiatr Scand</I> <STRONG>107</STRONG>, 155-158 (2003).</LI>
<BR>
<BR>

   <LI>Selective deficit of hippocampal N-acetylaspartate in
   antipsychotic-naive patients with schizophrenia.<BR> 
D Fannon, A Simmons, L Tennakoon, S O'C&#233;allaigh, A Sumich, V Doku, C
Shew, T Sharma<BR> 
<I>Biol Psychiatry</I> <STRONG>54</STRONG>, 587-598 (2003).</LI>
<BR>
<BR>

   <LI>Serial proton magnetic resonance spectroscopy of the brain in children
   undergoing cardiac surgery.<BR> 
S Ashwal, BA Holshouser, MJ del Rio, KA Tong, RL Applegate, LL Bailey<BR> 
<I>Pediatr Neurol</I> <STRONG>29</STRONG>, 99-110 (2003).</LI>
<BR>
<BR>

   <LI>Quantitative proton magnetic resonance spectroscopy of children with
   adrenoleukodystrophy before and after hematopoietic stem cell
   transplantation.<BR> 
P Dechent, J Finsterbusch, B Wilken, K Brockmann, F Hanefeld, J Frahm<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 139 (2003).</LI>
<BR>
<BR>

   <LI>Improvement of reproducibility by selection of MRS data depending on
   spectral quality expressed by lower bounds of linear model curve 
fitting.<BR> 
H Kubo, M Harada, M Sakama, N Nishitani<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 148 (2003).</LI>
<BR>
<BR>

   <LI>Striatal neurochemical changes in transgenic Huntington's disease mice
   detected by <I>in vivo</I> <SUP>1</SUP>H NMR spectroscopy.<BR> 
I Tkac, CD Keene, PG Henry, WC Low, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 192 (2003).</LI>
<BR>
<BR>

   <LI>Dietary creatine supplementation in a mouse model of Huntington's
   disease.<BR> 
RA Page, A Bainbridge, DA West, JS Thornton, HJ Parkes, EB Cady, GP Bates, B
Woodman, RJ Ordidge, CA Davie<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 194 (2003).</LI>
<BR>
<BR>

   <LI>Towards <I>in vivo</I> <SUP>13</SUP>C isotopomer analysis in the rat
   brain.<BR> 
PG Henry, I Tkac, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 260 (2003).</LI>
<BR>
<BR>

   <LI>Metabolic flux measurement from a 8 microliter volume in the rat brain
   using <I>ex vivo</I> <SUP>1</SUP>H-{<SUP>13</SUP>C} NMR spectroscopy
   combined with LCModel analysis.<BR> 
J Valette, F Vaufrey, PG Henry, G Bonvento, F Boumezbeur, P Hantraye, G
Bloch, V Lebon<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 262 (2003).</LI>
<BR>
<BR>

   <LI>Anatomical and neurochemical changes in minimal hepatic encephalopathy
   and their neuropsychological correlates.<BR> 
N Wyckoff, N Binesh, M Bugbee, K Yue, M Green, S Han, MA Thomas<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 279 (2003).</LI>
<BR>
<BR>

   <LI>Neurochemical profile of childhood adrenoleukodystrophy by
   <SUP>1</SUP>H MRS at 4 Tesla.<BR> 
G Oz, I Tkac, IY Choi, KJ Bjoraker, EG Shapiro, LR Charnas, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 330 (2003).</LI>
<BR>
<BR>

   <LI>Multinuclear MRS screening of untreated pediatric brain tumors.<BR> 
S Bluml, MJ Albers, MD Krieger, FH Gilles, MD Nelson<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 337 (2003).</LI>
<BR>
<BR>

   <LI>Anterior cingulate and amygdalar 1H MRS abnormalities in
   childhood autism.<BR> 
J O'Neill, J Levitt, JT McCracken, AW Toga, JR Alger<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 338 (2003).</LI>
<BR>
<BR>

   <LI>Comparison of metabolite T1 relaxation times in different brain regions
   at 1.5 and 3 Tesla.<BR> 
T Ethofer, I Mader, U Seeger, A Ludolph, W Grodd, U Klose<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 434 (2003).</LI>
<BR>
<BR>

   <LI>Age-related changes of cerebral metabolite concentrations: a
   quantitative proton MR spectroscopic study.<BR> 
N Hattori, K Abe, M Umeda, M Fukunaga, N Inoue, Y Someya, M Matsui, S Sakoda,
T Sawada<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 435 (2003).</LI>
<BR>
<BR>

   <LI>Short TE proton spectroscopy in variant and familial Creutzfeldt Jakob
   disease.<BR> 
R Cordery, D MacManus, J Collinge, M Rossor, A Waldman<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 438 (2003).</LI>
<BR>
<BR>

   <LI>Absolute quantification of metabolic changes in the frontal brain of
   depressive patients before and after treatment: a proton MRS study at 3 
T.<BR> 
S Gruber, R Frey, A Stadlbauer, V Mlynarik, S Kasper, E Moser<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 440 (2003).</LI>
<BR>
<BR>

   <LI>Statistical evaluation of 1H-MR spectra of the brain in situ
   for quantitative determination of postmortem intervals (PMI).<BR> 
E Scheurer, M Ith, D Dietrich, R Kreis, J Huesler, R Dirnhofer, C Boesch<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 568 (2003).</LI>
<BR>
<BR>

   <LI>Combination of <SUP>13</SUP>C NMR spectroscopy with <SUP>18</SUP>FDG
   detection reveals similar oxidative and glycolytic metabolism increases in
   the rat brain under physiological stimulation.<BR> 
J Valette, G Bonvento, F Vaufrey, L Besret, PG Henry, F Pain, F Boumezbeur, P
Hantraye, G Bloch, V Lebon<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 576 (2003).</LI>
<BR>
<BR>

   <LI>SESAME: An interleaved multislice chemical shift imaging method with
   spatial presaturation and selective excitation.<BR> 
R Katz-Brull, N Sailasuta, T Raidy, RE Lenkinski<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1132 (2003).</LI>
<BR>
<BR>

   <LI>Feasibility of highly resolved <I>in vivo</I> <SUP>1</SUP>H NMR
   spectroscopy of the mouse brain at 9.4 Tesla.<BR> 
I Tkac, PG Henry, P Andersen, CD Keene, WC Low, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1148 (2003).</LI>
<BR>
<BR>

   <LI>Quantitative mapping of Glx and myo-inositol in human brain by MR
   spectroscopic imaging at 3 Tesla.<BR> 
Y Someya, N Hattori, M Umeda, M Fukunaga, N Inoue, M Matsui, T Sawada<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1154 (2003).</LI>
<BR>
<BR>

   <LI>Metabolite quantitation in the monkey brain by <SUP>1</SUP>H MRS using
   LCModel and MRI automatic segmentation.<BR> 
F Boumezbeur, L Besret, R Maroy, F Vaufrey, P Hantraye, V Lebon, G Bloch<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1156 (2003).</LI>
<BR>
<BR>

   <LI>GUI for automatic post processing and display of 2D-SI data sets with
   LCModel.<BR> 
C Ko, B Kreher, M Buechert<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1157 (2003).</LI>
<BR>
<BR>

   <LI>T2-based segmentation of periventricular volumes for quantification of
   MR spectra of multiple sclerosis lesions.<BR> 
G Helms<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1162 (2003).</LI>
<BR>
<BR>

   <LI>LCModel analysis of spectra edited for glutathione (GSH).<BR> 
M Terpstra, PG Henry, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1166 (2003).</LI>
<BR>
<BR>

   <LI>Estimation of the cerebral metabolite concentrations in pure gray
   matter and white matter by <I>in vivo</I> proton MR spectroscopy.<BR> 
N Hattori, K Abe, M Umeda, M Fukunaga, N Inoue, Y Someya, M Matsui, S Sakoda,
T Sawada<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1167 (2003).</LI>
<BR>
<BR>

   <LI>Cerebral metabolite concentrations in pure gray and white matter
   calculated by proton MR spectroscopy and image segmentation.<BR> 
U Seeger, T N&auml;gele, I Mader, M Erb, T Ethofer, U Klose<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1168 (2003).</LI>
<BR>
<BR>

   <LI>Absolute quantification of brain metabolites in a mouse model of
   Huntington's disease.<BR> 
A Bainbridge, RA Page, DA West, EB Cady, AN Priest, JS Thornton, GP Bates, B
Woodman, RJ Ordidge, CA Davie<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1954 (2003).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy in an animal model of
   Parkinson's disease: effect of L-DOPA or Pramipexole treatment.<BR> 
M Delfino, G Murer, C Trenkwalder, O Gershanik, D Auer<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1956 (2003).</LI>
<BR>
<BR>

   <LI>Quantitative proton MRS detects different cerebral metabolic responses
   of mouse strains to global ischemia.<BR> 
O Natt, A Schwarcz, T Watanabe, S Boretius, J Frahm, T Michaelis<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1960 (2003).</LI>
<BR>
<BR>

   <LI>Evidence that GAD65 mediates a major fraction of GABA synthesis during
   seizures.<BR> 
AB Patel, GM Chowdhury, RA de Graaf, DL Rothman, B Wang, KL Behar<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1965 (2003).</LI>
<BR>
<BR>

   <LI>Glucose and glial-neuronal metabolism in alpha-chloralose anesthetized
   rats measured by <I>in vivo</I> <SUP>13</SUP>C NMR spectroscopy.<BR> 
PG Henry, S Crawford, G Oz, K Ugurbil, R Gruetter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1967 (2003).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy at 7 Tesla in the macaque monkey.<BR> 
J Pfeuffer, C Juchem, H Merkle, NK Logothetis<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1971 (2003).</LI>
<BR>
<BR>

   <LI>Is physiological motion important in MRS of the brain at 3T:
   Frame-to-frame PRESS acquisitions.<BR> 
R Katz-Brull, RE Lenkinski<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1990 (2003).</LI>
<BR>
<BR>

   <LI>Quantitative proton MRS in Lhermitte-Duclos disease.<BR> 
G Helms, D Greitz, O Flodmark<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1995 (2003).</LI>
<BR>
<BR>

   <LI>Quantitation of GABA in human brain using MEGA-PRESS editing and LCM
   analysis.<BR> 
M Wylezinska, P Matthews, P Jezzard<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 1997 (2003).</LI>
<BR>
<BR>

   <LI>Altered glutamate/glutamine levels within the left dorsolateral
   prefrontal cortex in acute mania - impact of tissue segmentation and
   related corrections.<BR> 
B Pfleiderer, N Michael, M G&ouml;sling, V Arolt, W Heindel <BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2004 (2003).</LI>
<BR>
<BR>

   <LI>Adolescents at high risk for schizophrenia studied by 1H MRS.<BR> 
C Hanstock, P Allen, A Valiakalayil, L Paulson, P Tibbo<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2009 (2003).</LI>
<BR>
<BR>

   <LI>Medial temporal lobe changes in first episode psychosis measured by
   <SUP>1</SUP>H MRS at 3T.<BR> 
RM Wellard, SJ Wood, GE Berger, PD McGorry, GD Jackson, C Pantelis<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2011 (2003).</LI>
<BR>
<BR>

   <LI>Fronto-temporal connectivity and violence in schizophrenia: A 1H-MRS
   study.<BR> 
R Jones, A Simmons, N Tunstall, E Daly, M Isaac, D Murphy<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2012 (2003).</LI>
<BR>
<BR>

   <LI>Metabolite changes identified by serial proton magnetic resonance
   spectroscopy can differentiate long-term neurologic outcome in traumatic
   brain injury.<BR> 
BA Holshouser, KA Tong, A Colohan, L Shutter<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2032 (2003).</LI>
<BR>
<BR>

   <LI>MRS and MRI insights into the diagnosis of the heredo-degenerative
   ataxias.<BR> 
M Viau, C Arseneau, C Bard, S Fontaine, L Marchand, J L&#233;veill&#233;, Y
Boulanger<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2048 (2003).</LI>
<BR>
<BR>

   <LI>Frontal lobe CSI abnormalities in obstructive sleep apnea.<BR> 
RS Briellmann, F O'Donoghue, RM Wellard, T Waites, P Rochford, R Pierce, GD
Jackson<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2061 (2003).</LI>
<BR>
<BR>

   <LI>Grey and white matter abnormalities in patients with chronic toxic
   encephalopathy: a preliminary study using DTI and 1H MR spectroscopy.<BR> 
C Lavini, I Visser, MM De Win, CB Majoie, EM Wekking, L Reneman, G van der
Laan, GJ den Heeten<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2294 (2003).</LI>
<BR>
<BR>

   <LI>Reproducibility of proton magnetic resonance spectroscopy in 
children.<BR> 
FP MacMaster, N Carrey, M Given, S Sullivan, MH Schmidt<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2522 (2003).</LI>
<BR>
<BR>

   <LI>3-Nitropropionic acid increases cortical and hippocampal, but not
   striatal, taurine in the rat: Metabolic profiling with HR-MAS 1H-MRS.<BR> 
TR Mitchell, MP Galloway, N Seraji-Bozorgzad, GJ Moore<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2616 (2003).</LI>
<BR>
<BR>

   <LI>Opposite effects of MDMA and SKF-38393 on striatal GABA: Neurochemical
   profile with HR-MAS 1H-MAS.<BR> 
MP Galloway, TR Mitchell, N Seraji-Bozorgzad, DA Briston, J Chioini, ST
Fricke, GJ Moore<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2617 (2003).</LI>
<BR>
<BR>

   <LI>Brain metabolism in vascular dementia and Alzheimer's disease assessed
   by quantitative in vivo proton MR spectroscopy.<BR> 
U Pilatus, A du Mesnil de Rochemont, S Herminghaus, L Froelich, J Peters, T
Kratzsch, K Maurer, H Lanfermann, FE Zanella<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2623 (2003).</LI>
<BR>
<BR>

   <LI>Diffusion tensor imaging in ALS compared with proton MR 
spectroscopy.<BR> 
IK Mader, M Erb, M Gleichmann, JB Schulz, W Grodd, U Klose<BR> 
<I>Proc ISMRM</I> <STRONG>11</STRONG>, 2624 (2003).</LI>
<BR>
<BR>

   <LI>Brain metabolite composition during early human brain
   development as measured by quantitative in vivo <SUP>1</SUP>H magnetic
   resonance spectroscopy.<BR> 
R Kreis, L Hofmann, B Kuhlmann, C Boesch, E Bossi, PS H&uuml;ppi,<BR> 
<I>Magn Reson Med</I> <STRONG>48</STRONG>, 949-958 (2002).</LI>
<BR>
<BR>

   <LI>Reproducibility of <I>in vivo</I> metabolite quantification with
   proton magnetic resonance spectroscopic imaging.<BR> 
DT Chard, MA McLean, GJM Parker, DG MacManus, DH Miller,<BR> 
<I>J Magn Reson Imaging</I> <STRONG>15</STRONG>, 219-225 (2002).</LI>
<BR>
<BR>

   <LI>Valproate-induced encephalopathy: Assessment with MR imaging
   and <SUP>1</SUP>H MR spectroscopy.<BR> 
S Ziyeh, T Thiel, J Spreer, J Klisch, M Schumacher,<BR> 
<I>Epilepsia</I> <STRONG>43</STRONG>, 1101-1105 (2002).</LI>
<BR>
<BR>

   <LI>Distinctly abnormal brain metabolism in late-onset ornithine
      transcarbamylase deficiency.<BR> 
J Takanashi, A Kurihara, M Tomita, M Kanazawa, S Yamamoto, F Morita, H
      Ikehira, S Tanada, Y Kohno,<BR> 
<I>Neurology</I> <STRONG>59</STRONG>, 210-214 (2002).</LI>
<BR>
<BR>

   <LI>Observation and identification of metabolites emerging during
   postmortem decomposition of brain tissue by means of <I>in situ</I>
   <SUP>1</SUP>H-magnetic resonance spectroscopy.<BR> 
M Ith, P Bigler, E Scheurer, R Kreis, L Hofmann, R Dirnhofer, C Boesch,<BR> 
<I>Magn Reson Med</I> <STRONG>48</STRONG>, 915-920 (2002).</LI>
<BR>
<BR>

   <LI>A short-echo-time proton magnetic resonance spectroscopic
   imaging study of temporal lobe epilepsy.<BR> 
RJ Simister, FG Woermann, MA McLean, PA Bartlett, GJ Barker, JS Duncan,<BR> 
<I>Epilepsia</I> <STRONG>43</STRONG>, 1021-1031 (2002).</LI>
<BR>
<BR>

   <LI>Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease
      with PLP1 duplication.<BR> 
J Takanashi, K Inoue, M Tomita, A Kurihara, F Morita, H Ikehira, S Tanada, E
      Yoshitome, Y Kohno,<BR> 
<I>Neurology</I> <STRONG>58</STRONG>, 237-241 (2002).</LI>
<BR>
<BR>

   <LI>Brain metabolite changes in cortical grey and normal-appearing
   white matter in clinically early relapsing-remitting multiple
   sclerosis.<BR> 
DT Chard, CM Griffin, MA McLean, P Kapeller, R Kapoor, AJ Thompson, DH 
Miller,<BR> 
<I>Brain</I> <STRONG>125</STRONG>, 2342-2352 (2002).</LI>
<BR>
<BR>

   <LI>Substance P receptor antagonist and clomipramine prevent
   stress-induced alterations in cerebral metabolites, cytogenesis
   in the dentate gyrus and hippocampal volume.<BR> 
MGC van der Hart, B Cz&#233;h, G de Biurrun, T Michaelis, T Watanabe, O Natt, J
      Frahm, E Fuchs,<BR>
<I>Molecular Psychiatry</I> <STRONG>7</STRONG>, 933-941 (2002).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine
   in Alzheimer's disease.<BR> 
N Hattori, K Abe, S Sakoda, T Sawada,<BR> 
<I>Neuroreport</I> <STRONG>13</STRONG>, 183-186 (2002).</LI>
<BR>
<BR>

   <LI>Reduced myo-inositol and total choline measured with cerebral
   MRS in acute thyrotoxic Graves' disease.<BR> 
TV Elberling, ER Danielsen, &#197;K Rasmussen, U Feldt-Rasmussen, G Waldemar, C
      Thomsen,<BR> 
<I>Neurology</I> <STRONG>60</STRONG>, 142-145 (2002).</LI>
<BR>
<BR>

   <LI>Application of NMR spectroscopy to monitoring MELAS treatment:
   A case report.<BR> 
HE M&ouml;ller, D Wiedermann, G Kurlemann, T Hilbich, G Schuierer,<BR> 
<I>Muscle Nerve</I> <STRONG>25</STRONG>, 593-600 (2002).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy of the thalamus in
   patients with chronic neuropathic pain after spinal cord injury.<BR> 
PM Pattany, RP Yezierski, EG Widerstr&ouml;m-Noga, BC Bowen, 
A Martinez-Arizala, BR Garcia, RM Quencer<BR> 
<I>Am J Neuroradiol</I> <STRONG>23</STRONG>, 901-905 (2002).</LI>
<BR>
<BR>

   <LI>Proton MRS in Kennedy disease: Absolute metabolite and
   macromolecular concentrations.<BR> 
I Mader, J Karitzky, U Klose, U Seeger, A Sperfeld, T Naegele, F Schick, A
      Ludolph, W Grodd,<BR> 
<I>J Magn Reson Imaging</I> <STRONG>16</STRONG>, 160-167 (2002).</LI>
<BR>
<BR>

   <LI>Frontal white matter biochemical abnormalities in late-life
   major depression detected with proton magnetic resonance
   spectroscopy.<BR> 
A Kumar, A Thomas, H Lavretsky, K Yue, A Huda, J Curran, T Venkatraman, L
      Estanol, J Mintz, M Mega, A Toga,<BR> 
<I>Am J Psychiatry</I> <STRONG>159</STRONG>, 630-636 (2002).</LI>
<BR>
<BR>

   <LI>Increase in amino acids in the pons after sleep deprivation: A
   pilot study using proton magnetic resonance spectroscopy.<BR> 
H Murck, T Struttmann, M Czisch, T Wetter, A Steiger, DP Auer,<BR> 
<I>Neuropsychobiology</I> <STRONG>45</STRONG>, 120-123 (2002).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy of neurometabolites in hepatic
   encephalopathy during L-ornithine-L-aspartate treatment -
   Results of a pilot study.<BR> 
A Delcker, B Turowski, U Mihm, P Raab, O Rusch, U Pilatus, S Zeuzem, FE
      Zanella,<BR> 
<I>Metab Brain Dis</I> <STRONG>17</STRONG>, 103-111 (2002).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy with metabolite nulling
   reveals regional differences of macromolecules in normal human
   brain.<BR> 
I Mader, U Seeger, J Karitzky, M Erb, F Schick, U Klose,<BR> 
<I>J Magn Reson Imaging</I> <STRONG>16</STRONG>, 538-546 (2002).</LI>
<BR>
<BR>

   <LI>Quantitative <SUP>1</SUP>H-magnetic resonance spectroscopy of human
   brain: Influence of composition and parameterization of the
   basis set in linear combination model-fitting.<BR> 
L Hofmann, J Slotboom, B Jung, P Maloca, C Boesch, R Kreis,<BR> 
<I>Magn Reson Med</I> <STRONG>48</STRONG>, 440-453 (2002).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H MRS brain measures and acute lorazepam administration in
   healthy human subjects.<BR> 
P Brambilla, JA Stanley, M Nicoletti, K Harenski, KF Wells, AG Mallinger, MS
      Keshavan, JC Soares,<BR> 
<I>Neuropsychopharmacology</I> <STRONG>26</STRONG>, 546-551 (2002).</LI>
<BR>
<BR>

   <LI>In vivo GABA+ measurement at 1.5T using a PRESS-localized
   double quantum filter.<BR> 
MA McLean, AL Busza, LL Wald, RJ Simister, GJ Barker, SR Williams,<BR> 
<I>Magn Reson Med</I> <STRONG>48</STRONG>, 233-241 (2002).</LI>
<BR>
<BR>

   <LI>Patients lacking the major CNS myelin protein, proteolipid
   protein 1, develop length-dependent axonal degeneration in the
   absence of demyelination and inflammation.<BR> 
JY Garbern, DA Yool, GJ Moore, IB Wilds, MW Faulk, M Klugmann, KA Nave, EA
      Sistermans, MS van der Knaap, TD Bird, ME Shy, JA Kamholz, IR Griffiths, 
      <BR> 
<I>Brain</I> <STRONG>125</STRONG>, 551-561 (2002).</LI>
<BR>
<BR>

   <LI>Effects of physiologic human brain motion on proton
   spectroscopy: Quantitative analysis and correction with cardiac
   gating.<BR> 
PM Pattany, IH Khamis, BC Bowen, K Goodkin, RG Weaver, JB Murdoch, MJD Post,
      RM Quencer,<BR> 
<I>Am J Neuroradiol</I> <STRONG>23</STRONG>, 225-230 (2002).</LI>
<BR>
<BR>

   <LI>New syndrome characterized by hypomyelination with atrophy of
   the basal ganglia and cerebellum.<BR> 
MSvan der Knaap, S Naidu, PJW Pouwels, S Bonavita, R van Coster, L Lagae, J
      Sperner, R Surtees, R Schiffmann, J Valk,<BR> 
<I>Am J Neuroradiol</I> <STRONG>23</STRONG>, 1466-1474 (2002).</LI>
<BR>
<BR>

   <LI>Thalamic neurodegeneration in multiple sclerosis.<BR> 
A Cifelli, M Arridge, P Jezzard, MM Esiri, J Palace, PM Matthews,<BR> 
<I>Ann Neurol</I> <STRONG>52</STRONG>, 650-653 (2002).</LI>
<BR>
<BR>

   <LI>Human brain: Biochemical lateralization in normal subjects.<BR> 
R Jayasundar,<BR> 
<I>Neurol India</I> <STRONG>50</STRONG>, 267-271 (2002).</LI>
<BR>
<BR>

   <LI>Frontal lobe myoinositol abnormalities in temporal lobe epilepsy.<BR> 
RM Wellard, RS Briellmann, A Syngeniotis, GD Jackson,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 418 (2002).</LI>
<BR>
<BR>

   <LI>A comparison of metabolite concentrations in primary generalised
      epilepsy and partial epilepsy using short echo time 1H spectroscopy and
      a double quantum GABA filter.<BR> 
RJ Simister, MA McLean, GJ Barker, JS Duncan,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 420 (2002).</LI>
<BR>
<BR>

   <LI>Influence of composition of the basis set in linear combination model
      fitting of <SUP>1</SUP>H-MR spectra of human brain.<BR> 
L Hofmann, C Boesch, R Kreis,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 527 (2002).</LI>
<BR>
<BR>

   <LI>On the quantification of low concentration metabolites by <SUP>1</SUP>H 
      NMR spectroscopy in human brain at 7 Tesla.<BR> 
I Tkac, K Ugurbil, R Gruetter,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 528 (2002).</LI>
<BR>
<BR>

   <LI>Metabolite nulling improves reliability of LCModel analysis of short
      echo time spectroscopy.<BR> 
MA McLean, RJ Simister, GJ Barker, JS Duncan,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 529 (2002).</LI>
<BR>
<BR>

   <LI>Automatic quantitation of <i>in vivo</I> <SUP>13</SUP>C spectra using
      LCModel.<BR> 
P-G Henry, I Tkac, R Gruetter,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 530 (2002).</LI>
<BR>
<BR>

   <LI>Identification of metabolites emerging during autolysis and bacterial
      heterolysis of decomposing brain tissue by <SUP>1</SUP>H-MRS <I>in
	situ</I> and <I>in vitro</I>.<BR> 
M Ith, P Bigler, E Scheurer, R Kreis, L Hofmann, R Dirnhofer, C Boesch,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 580 (2002).</LI>
<BR>
<BR>

   <LI>Antidepressants prevent stress-induced reductions of cerebral
      metabolites.<BR> 
T Michaelis, T Watanabe, O Natt, S Boretius, M van der Hart, B Czeh, G de
      Biurrun, E Fuchs, J Frahm,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 584 (2002).</LI>
<BR>
<BR>

   <LI>MDMA ("Ecstasy") increases striatal but not prefrontal GABA in rat
      brain: Studies with high-resolution magic angle spinning proton magnetic 
      resonance spectroscopy (HR-MAS 1H-MRS).<BR> 
MP Galloway, ST Fricke, T Mitchell, N Seraji-Bozorgzad, GJ Moore,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 585 (2002).</LI>
<BR>
<BR>

   <LI>Short TE proton MRS in Graves' disease.<BR> 
ER Danielsen, T Elberling, G Waldemar, U Feldt-Rasmussen, C Thomsen,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 697 (2002).</LI>
<BR>
<BR>

   <LI>Brain glycogen: An endogenous, insulin-sensitive energy reservoir.<BR> 
I-Y Choi, R Gruetter,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 944 (2002).</LI>
<BR>
<BR>

   <LI>Proton MRS of rat brain after chronic repetitive transcranial magnetic
      stimulation.<BR> 
T Michaelis, D Liebetanz, T Watanabe, B Czeh, W Paulus, E Fuchs, J Frahm<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 951 (2002).</LI>
<BR>
<BR>

   <LI><I>Ex vivo</I> neurochemical kinetics in brain tissue specimens
      monitored via quantitative HR-MAS proton magnetic resonance spectroscopy 
      at 11.7T.<BR> 
ST Fricke, MP Galloway, N Seraji-Bozorgzad, TR Mitchell, S Posse, GJ 
Moore,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 952 (2002).</LI>
<BR>
<BR>

   <LI>Metabolite and diffusion changes in the rat brain after Leksell Gamma
      Knife irradiation.<BR> 
V Herynek, M Burian, D Jir&#225;k, R Lisc&#225;k, K N&#225;mestkov&#225;, M
      H&#225;jek, E Sykov&#225;<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 959 (2002).</LI>
<BR>
<BR>

   <LI><I>in vivo</I> MR studies in transgenic mouse model of Huntington's
      disease.<BR> 
RA Page, DA West, EB Cady, JS Thornton, GP Bates, B Woodman, AN Priest, RJ
      Ordidge, CA Davie<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 960 (2002).</LI>
<BR>
<BR>

   <LI>Striatal oxidative metabolic failure in an improved rat model of
      Huntington's disease monitored via HR-MAS proton magnetic resonance
      spectroscopy at 11.7T.<BR> 
TR Mitchell, MP Galloway, ST Fricke, N Seraji-Bozorgzad, C Zajac-Benitez, GJ
      Moore,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 961 (2002).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H MRS in mild cognitive impairment (MCI) and Alzheimer's
      disease (AD); Comparison of 1.5T and 3T.<BR> 
K Kantarci, RC Petersen, BF Boeve, DS Knopman, SD Edland, GE Smith, RJ Ivnik,
      EG Tangalos, CR Jack, Jr,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 971 (2002).</LI>
<BR>
<BR>

   <LI>Reproducibilty of magnetic resonance spectroscopy (MRS) measurements in 
      schizophrenic patients.<BR> 
P Mullins, LM Rowland, J Bustillo, WM Brooks,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 973 (2002).</LI>
<BR>
<BR>

   <LI>Regional metabolic effects of sleep deprivation in depressed patients
      assessed by proton magnetic resonance spectroscopy.<BR> 
DP Auer, D Schmid, T Merl, H Murck, A Steiger,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 977 (2002).</LI>
<BR>
<BR>

   <LI>Absolute quantification of metabolic changes in the brain of depressive 
      patients.<BR> 
A Stadlbauer, S Gruber, R Frey, V Mlyn&#225;rik, S Kasper, E Moser,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 978 (2002).</LI>
<BR>
<BR>

   <LI>Staging of progressive multifocal leukoencephalopathy lesions using
      proton MR spectroscopy at 3T.<BR> 
R Katz-Brull, IJ Koralnik, MA McLean, RE Lenkinski,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 981 (2002).</LI>
<BR>
<BR>

   <LI>Proton MRS of childhood adrenoleukodystrophy at 4 Tesla.<BR> 
G &Ouml;z, I Tk&#225;c, I-Y Choi, JT Vaughan, EG Shapiro, MC Gibbs, LR
      Charnas, R Gruetter,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 982 (2002).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy of the thalamus: Evaluation of
      patients with chronic neuropathic pain following spinal cord injury.<BR> 
PM Pattany, BC Bowen, RP Yezierski, EG Widerstr&ouml;m-Noga, A 
Martinez-Arizala, RM Quencer,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 987 (2002).</LI>
<BR>
<BR>

   <LI>Gender and age effects in human white matter on MR spectroscopy at 4
      Tesla.<BR> 
K Zhong, L Chang, D Carasig, L Zimmerman, T Ernst,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 1005 (2002).</LI>
<BR>
<BR>

   <LI>Ketogenic diet in intractable epilepsy: An <SUP>1</SUP>H-MRS follow-up
      study in children.<BR> 
DP Auer, M Wilke, G Liebhaber, F Baumeister,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 1032 (2002).</LI>
<BR>
<BR>

   <LI>Influence of increased tissue water content in multiple sclerosis
      lesions on the metabolite concentrations as measured by proton MR
      spectroscopy.<BR> 
L Stawiarz, H Link,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 1203 (2002).</LI>
<BR>
<BR>

   <LI>Morphologic and metabolic alterations in a APP/PS double-transgenic
      mouse model for Alzheimer's disease.<BR> 
M von Kienlin, B Kuennecke, G Higgins, H. Bluethmann, JG Richards,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 1208 (2002).</LI>
<BR>
<BR>

   <LI>Proton spectroscopy of white matter in the healthy elderly:
      Relationships with age, working memory, and APOE status.<BR> 
RA Yeo, I Driscoll, J Bish, D Weers, H Petropoulos, R Jung, S Kernan, R
      Baumgartner, P Garry, WB Brooks,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 1317 (2002).</LI>
<BR>
<BR>

   <LI>Detection of elevated levels of glutathione in meningiomas by
      quantitative <I>in vivo</I> <SUP>1</SUP>H MRS.<BR> 
KS Opstad, SW Provencher, BA Bell, JR Griffiths , FA Howe,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 2035 (2002).</LI>
<BR>
<BR>

   <LI>Characterization of an intracranial neoplasm of lipoid origin by
      <SUP>1</SUP>H MR spectroscopy.<BR> 
M Rijpkema, Y van der Meulen, J Schuuring, E Mooyaart, M van der Graaf, A
      Heerschap,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 2042 (2002).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> localized <SUP>1</SUP>H-MR spectroscopy on the effects
      of radiation damage in the rat cervical spinal cord.<BR> 
JA Pikkemaat, HP Bijl, MEP Philippens, DWJ Klomp, JJA van Asten, AJ van der
      Kogel, A Heerschap,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 2148 (2002).</LI>
<BR>
<BR>

   <LI>Reproducibility of absolute metabolite concentration evaluated by
      intraclass correlation coefficient using clinical MR apparatus.<BR> 
H Kubo, M Harada, M Sakama, H Nishitani,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 2515 (2002).</LI>
<BR>
<BR>

   <LI>Effects of physiologic human brain motion on proton spectroscopy:
      Quantitative analysis and correction by cardiac gating.<BR> 
PM Pattany, BC Bowen, IH Khamis, K Goodkin, RG Weaver, JB Murdoch, RM Quencer,
<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 2518 (2002).</LI>
<BR>
<BR>

   <LI>MRS of pediatric bipolar and disruptive behavior disorders.<BR> 
P Davanzo, S Barnett, TN Venkatraman, K Yue, M Frye, N Binesh, A Huda, MA
      Thomas,<BR> 
<I>Proc ISMRM</I> <STRONG>10</STRONG>, 2553 (2002).</LI>
<BR>
<BR>

   <LI>Automatic quantitation of localized <I>in vivo</I> <SUP>1</SUP>H
      spectra with LCModel.<BR>
SW Provencher,<BR> 
<I>NMR Biomed</I> <STRONG>14</STRONG>, 260-264 (2001).</LI>
<BR>
<BR>

   <LI>Subtle prefrontal neuropathology in a pilot magnetic resonance
      spectroscopy study in patients with borderline personality disorder.<BR> 
L Tebartz van Elst, T Thiel, B Hesslinger, K Lieb, M Bohus, J Hennig, D Ebert,
<BR> 
<I>J Neuropsychiatry Clin Neurosci</I> <STRONG>13</STRONG>, 511-514 
(2001).</LI>
<BR>
<BR>

   <LI>Altered white and gray matter metabolism in CADASIL.  A proton MR
	spectroscopy and <SUP>1</SUP>H-MRSI study.<BR> 
DP Auer <I>et al</I>, <I>Neurology</I>
      <STRONG>56</STRONG>, 635-642 (2001).</LI>
<BR>
<BR>

   <LI>Stress-induced changes in cerebral metabolites, hippocampal volume, and 
      cell proliferation are prevented by antidepressant treatment with
      tianeptine.<BR> 
B Cz&#233;h <I>et al</I>, <I>Proc Natl Acad Sci USA</I>
      <STRONG>98</STRONG>, 12796-12801 (2001).</LI>
<BR>
<BR>

   <LI>Attention-deficit disorder in adults with or without hyperactivity:
      where is the difference?  A study in humans using short echo
      <SUP>1</SUP>H-magnetic resonance spectroscopy.<BR> 
B Hesslinger <I>et al</I>, <I>Neurosci Lett</I>
      <STRONG>304</STRONG>, 117-119 (2001).</LI>
<BR>
<BR>

   <LI><I>In Vivo</I> short echo time <SUP>1</SUP>H-magnetic resonance
      spectroscopic imaging (MRSI) of the temporal lobes.<BR> 
MA McLean <I>et al</I>, <I>Neuroimage</I>
      <STRONG>14</STRONG>, 501-509 (2001).</LI>
<BR>
<BR>

   <LI>Absence of N-acetylaspartate in the human brain: Impact on
      neurospectroscopy?<BR> 
E Martin <I>et al</I>, <I>Ann Neurol</I>
      <STRONG>49</STRONG>, 518-521 (2001).</LI><BR>
Reply.<BR>
E Martin <I>et al</I>, <I>Ann Neurol</I>
      <STRONG>50</STRONG>, 824-825 (2001).</LI>
<BR>
<BR>

   <LI>Gender-specific alterations of cerebral metabolite with aging and
      cortisol treatment.<BR> 
T Michaelis <I>et al</I>, <I>J Psychiatric Res</I>
      <STRONG></STRONG>, 231-237 (2001).</LI>
<BR>
<BR>

   <LI>Volume correction for edema in single-volume proton MR spectroscopy of
      contrast-enhancing multiple sclerosis lesions.<BR> 
G Helms, <I>Magn Reson Med</I>
      <STRONG>46</STRONG>, 256-263 (2001).</LI>
<BR>
<BR>

   <LI>Reduced NAA in the thalamus and altered membrane and glial metabolism
      in schizophrenic patients detected by <SUP>1</SUP>H-MRS and tissue
      segmentation.<BR>
DP Auer <I>et al</I>, <I>Schizophr Res</I>
      <STRONG>52</STRONG>, 87-99 (2001).</LI>
<BR>
<BR>

   <LI>Chemical pathology in brain white matter of recently detoxified
      alcoholics: A <SUP>1</SUP>H magnetic resonance spectroscopy 
      investigation of alcohol-associated frontal lobe injury.<BR> 
BC Schweinsburg <I>et al</I>, <I>Alcohol Clin Exp Res</I>
      <STRONG>25</STRONG>, 924-934 (2001).</LI>
<BR>
<BR>

   <LI>Case study: Caudate glutamatergic changes with paroxetine persist after 
      medication discontinuation in pediatric OCD.<BR> 
J Bolton <I>et al</I>, <I>J Am Acad Child Adolesc Psychiatry</I>
      <STRONG>40</STRONG>, 903-906 (2001).</LI>
<BR>
<BR>

   <LI>Metabolic changes in quinolinic acid-lesioned rat striatum detected
      non-invasively by <I>in vivo</I> <SUP>1</SUP>H NMR spectroscopy.<BR> 
I Tkac <I>et al</I>, <I>J Neurosci Res</I>
      <STRONG>66</STRONG>, 891-898 (2001).</LI>
<BR>
<BR>

   <LI>Preliminary evidence for neuronal damage in cortical grey matter and
      normal appearing white matter in short duration relapsing-remitting
      multiple sclerosis: a quantitative MR spectroscopic imaging study.<BR> 
P Kapeller <I>et al</I>, <I>J Neurol</I>
      <STRONG>248</STRONG>, 131-138 (2001).</LI>
<BR>
<BR>

   <LI>Correlation of the apparent diffusion coefficient and the creatine
      level in early ischemic stroke: A comparison of different patterns by
      magnetic resonance.<BR> 
H Rumpel <I>et al</I>, <I>J Magn Reson Imaging</I>
      <STRONG>13</STRONG>, 335-343 (2001).</LI>
<BR>
<BR>

   <LI>Quantitative short echo time proton magnetic resonance spectroscopic
      imaging study of malformations of cortical development causing
      epilepsy.<BR>
FG Woermann <I>et al</I>, <I>Brain</I>
      <STRONG>124</STRONG>, 427-436 (2001).</LI>
<BR>
<BR>

   <LI>Temporal lobe changes following radiation therapy: imaging and proton
      MR spectroscopic findings.<BR> 
VFH Chong <I>et al</I>, <I>Eur Radiol</I>
      <STRONG>11</STRONG>, 317-324 (2001).</LI>
<BR>
<BR>

   <LI>Diagnosis of a multifocal B cell lymphoma with preceding demyelinating
      central nervous system lesions by single voxel proton MR
      spectroscopy.<BR>
T Kuhlmann <I>et al</I>, <I>J Neurol Neurosurg Psychiatry</I>
      <STRONG>70</STRONG>, 259-262 (2001).</LI>
<BR>
<BR>

   <LI>Homozygosity (E140K) in <I>SCO2</I> causes delayed infantile onset of
      cardiomyopathy and neuropathy.<BR> 
M Jaksch <I>et al</I>, <I>Neurology</I>
      <STRONG>57</STRONG>, 1440-1446 (2001).</LI>
<BR>
<BR>

   <LI>MR in phenylketonuria-related brain lesions.<BR> 
M Dezortov&#225; <I>et al</I>, <I>Acta Radiologica</I>
      <STRONG>42</STRONG>, 459-466 (2001).</LI>
<BR>
<BR>

   <LI>Restoration of motion-related signal loss and line-shape deterioration
      of proton MR spectra using the residual water as intrinsic 
reference.<BR> 
G Helms <I>et al</I>, <I>Magn Reson Med</I>
      <STRONG>46</STRONG>, 395-400 (2001).</LI>
<BR>
<BR>

   <LI>Improved analysis of <SUP>1</SUP>H-MR spectra in the presence of mobile 
      lipids.<BR> 
DP Auer <I>et al</I>, <I>Magn Reson Med</I>
      <STRONG>46</STRONG>, 615-618 (2001).</LI>
<BR>
<BR>

   <LI>Differentiation of glucose transport in human brain gray and white
      matter.<BR> 
RA de Graaf <I>et al</I>, <I>J Cereb Blood Flow Metab</I>
      <STRONG>21</STRONG>, 483-492 (2001).</LI>
<BR>
<BR>

   <LI>Clinical and biochemical effects of zileuton in patients with
      Sj&ouml;gren-Larsson syndrome.<BR>
MAAP Willemsen <I>et al</I>, <I>Eur J Pediatr</I>
      <STRONG>160</STRONG>, 711-717 (2001).</LI>
<BR>
<BR>

   <LI>Magnetic resonance markers of ischaemia: their correlation with
      vasodilatory reserve in patients with carotid artery stenosis and
      occlusion.<BR>
D Lythgoe <I>et al</I>, <I>J Neurol Neurosurg Psychiatry</I>
      <STRONG>71</STRONG>, 58-62 (2001).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> and <I>in vitro</I> NMR spectroscopy reveal a putative
      novel inborn error involving polyol metabolism.<BR> 
SH Moolenaar <I>et al</I>, <I>NMR Biomed</I>
      <STRONG>14</STRONG>, 167-176 (2001).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy with metabolite-nulling reveals elevated
      macromolecules in acute multiple sclerosis.<BR> 
I Mader <I>et al</I>, <I>Brain</I>
      <STRONG>124</STRONG>, 953-961 (2001).</LI>
<BR>
<BR>

   <LI>Magnetization transfer of water T<SUB>2</SUB> relaxation components in
      human brain: implications for T<SUB>2</SUB>-based segmentation of
      spectroscopic volumes.<BR> 
G Helms <I>et al</I>, <I>Magn Reson Imaging</I>
      <STRONG>19</STRONG>, 803-811 (2001).</LI>
<BR>
<BR>

   <LI>Volume-selective proton MR spectroscopy for <I>in vitro</I>
      quantification of anticonvulsants.<BR> 
J Braun <I>et al</I>, <I>Neuroradiology</I>
      <STRONG>43</STRONG>, 211-217 (2001).</LI>
<BR>
<BR>

   <LI>Metabolic information from the human fetal brain obtained with proton
      magnetic resonance spectroscopy.<BR> 
RD Kok <I>et al</I>, <I>Am J Obstet Gynecol</I>
      <STRONG>185</STRONG>, 1011-1015 (2001).</LI>
<BR>
<BR>

   <LI>Quantification of <SUP>1</SUP>H NMR spectra of the human brain using
      LCModel and spin simulations at 7 Tesla.<BR>
I Tkac <I>et al</I>, <I>Proc ISMRM</I>, 214 (2001).</LI>
<BR>
<BR>

   <LI>Evidence of subtle prefrontal neuropathology in patients with
      borderline personality disorder.  A pilot proton magnetic resonance
      spectroscopy study.<BR>
T Thiel <I>et al</I>, <I>Proc ISMRM</I>, 381 (2001).</LI>
<BR>
<BR>

   <LI>Is voxel composition and NAA as measured by <SUP>1</SUP>H MRS
      influenced by structural abnormalities associated with major depressive
      disorder?<BR>
B Pfleiderer <I>et al</I>, <I>Proc ISMRM</I>, 382 (2001).</LI>
<BR>
<BR>

   <LI>A short echo time proton magnetic resonance spectroscopic imaging study 
      of metabolites in temporal lobe epilepsy.<BR>
RJ Simister <I>et al</I>, <I>Proc ISMRM</I>, 387 (2001).</LI>
<BR>
<BR>

   <LI>Using <SUP>1</SUP>H-MR spectroscopy in forensic medicine to estimate
      the post-mortem interval: A pilot study in an animal model and its
      application to human brain.<BR>
M Ith <I>et al</I>, <I>Proc ISMRM</I>, 388 (2001).</LI>
<BR>
<BR>

   <LI>Absolute quantification of metabolites in white matter using MR
      spectroscopy in patients with MS or syndromes suggestive of MS with
      normal MRI scans of the brain.<BR>
M Gustafsson <I>et al</I>, <I>Proc ISMRM</I>, 467 (2001).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy with metabolite-nulling reveals elevated
      macromolecules in acute MS.<BR>
I Mader <I>et al</I>, <I>Proc ISMRM</I>, 468 (2001).</LI>
<BR>
<BR>

   <LI>T<SUB>2</SUB>-based volume correction for edema in single volume MRS of 
      contrast-enhancing multiple sclerosis lesions.<BR>
G Helms, <I>Proc ISMRM</I>, 469 (2001).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> quantification of metabolites in the hippocampus,
      striatum, and cortex of the developing neonatal rat.<BR>
I Tkac <I>et al</I>, <I>Proc ISMRM</I>, 488 (2001).</LI>
<BR>
<BR>

   <LI>Electroconvulsive therapy induces metabolic changes in severe depressed 
      patients in the anterior cingulum.<BR>
B Pfleiderer <I>et al</I>, <I>Proc ISMRM</I>, 558 (2001).</LI>
<BR>
<BR>

   <LI>Brain neurochemical abnormalities in childhood autism.<BR>
SD Friedman <I>et al</I>, <I>Proc ISMRM</I>, 577 (2001).</LI>
<BR>
<BR>

   <LI>Quantitative analysis of brain metabolites in 13 patients with
      Sj&ouml;gren-Larsson syndrome.<BR>
M van der Graaf <I>et al</I>, <I>Proc ISMRM</I>, 583 (2001).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> GABA measurement using a PRESS-localized double quantum
      filter in patients with malformations of cortical development and
      epilepsy.<BR>
M McLean <I>et al</I>, <I>Proc ISMRM</I>, 962 (2001).</LI>
<BR>
<BR>

   <LI>Metabolite T<SUB>1</SUB> in multiple sclerosis lesions differs from
      normal.<BR>
E Brief <I>et al</I>, <I>Proc ISMRM</I>, 983 (2001).</LI>
<BR>
<BR>

   <LI>Neurochemical correlates of late-life major depression.<BR>
A Kumar <I>et al</I>, <I>Proc ISMRM</I>, 1013 (2001).</LI>
<BR>
<BR>

   <LI>Metabolic changes in the brain of depressive patients.<BR>
S Gruber <I>et al</I>, <I>Proc ISMRM</I>, 1021 (2001).</LI>
<BR>
<BR>

   <LI>Brain and immune changes in response to psychosocial stress are
      reversed by tianeptine.<BR>
T Michaelis <I>et al</I>, <I>Proc ISMRM</I>, 1028 (2001).</LI>
<BR>
<BR>

   <LI>LC-Model analysis of anterior cingulate <SUP>1</SUP>H MRS in juvenile
      bipolar disorder.<BR>
PA Davanzo <I>et al</I>, <I>Proc ISMRM</I>, 1356 (2001).</LI>
<BR>
<BR>

   <LI>Parameterized evaluation of pathological macromolecules in proton MR
      spectra of the human brain.<BR>
U Seeger <I>et al</I>, <I>Proc ISMRM</I>, 1659 (2001).</LI>
<BR>
<BR>

   <LI>Metabolite quantitation reproducibility in serial <SUP>1</SUP>H-MRSI
      studies of human brain using a stereotactic immobilization/repositioning 
      frame.<BR>
AZ Damyanovich <I>et al</I>, <I>Proc ISMRM</I>, 1681 (2001).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> metabolite T<SUB>2</SUB> accurately measured with large
      TE range.<BR>
E Brief <I>et al</I>, <I>Proc ISMRM</I>, 1684 (2001).</LI>
<BR>
<BR>

   <LI>Improved analysis of <SUP>1</SUP>H-MR spectra in the presence of mobile 
      lipids: Impact on grading of malignant gliomas.<BR>
DP Auer <I>et al</I>, <I>Proc ISMRM</I>, 2283 (2001).</LI>
<BR>
<BR>

   <LI>Characterization of oligodendrogliomas using short echo time 2D
      <SUP>1</SUP>H MRSI.<BR>
M Rijpkema <I>et al</I>, <I>Proc ISMRM</I>, 2304 (2001).</LI>
<BR>
<BR>

   <LI>Quantitative analysis of short echo time <SUP>1</SUP>H-MRSI of cerebral 
	gray and white matter.<BR> 
MA McLean <I>et al</I>, <I>Magn Reson Med</I>
      <STRONG>44</STRONG>, 401-411 (2000).</LI>
<BR>
<BR>

   <LI>Reduced glutamate in the anterior cingulate cortex in depression: An
      <I>in vivo</I> proton magnetic resonance spectroscopy study.<BR> 
DP Auer  <I>et al</I>, <I>Biol Psychiatry</I>
      <STRONG>47</STRONG>, 305-313 (2000).</LI>
<BR>
<BR>

   <LI>Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis
      plaques: Absolute metabolic values over 2 years during a clinical
      pharmacological study.<BR> 
I Mader <I>et al</I>, <I>Am J Neuroradiol</I>
      <STRONG>21</STRONG>, 1220-1227 (2000).</LI>
<BR>
<BR>

   <LI>MR spectroscopy shows reduced frontal lobe concentrations of
      <I>N</I>-acetyl aspartate in patients with juvenile myoclonic
      epilepsy.<BR>  
I Savic <I>et al</I>, <I>Epilepsia</I>
      <STRONG>41</STRONG>, 290-296 (2000).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> <SUP>1</SUP>H-magnetic resonance spectroscopy of the
      spinal cord in humans.<BR> 
B G&#243;mez-Ans&#243;n <I>et al</I>, <I>Neuroradiology</I>
      <STRONG>42</STRONG>, 515-517 (2000).</LI>
<BR>
<BR>

   <LI><I>N</I>-Acetylaspartate concentration in the anterior cingulate of
      maltreated children and adolescents with PTSD.<BR> 
MD De Bellis <I>et al</I>, <I>Am J Psychiatry</I>
      <STRONG>157</STRONG>, 1175-1177 (2000).</LI>
<BR>
<BR>

   <LI>Mental retardation and behavioral problems as presenting signs of a
      creatine synthesis defect.<BR> 
MS van der Knaap <I>et al</I>, <I>Ann Neurol</I>
      <STRONG>47</STRONG>, 540-543 (2000).</LI>
<BR>
<BR>

   <LI>Quantitative proton magnetic resonance spectroscopy of focal brain
      lesions.<BR> 
B Wilken <I>et al</I>, <I>Pediatr Neurol</I>
      <STRONG>23</STRONG>, 22-31 (2000).</LI>
<BR>
<BR>

   <LI>A <SUP>1</SUP>H magnetic resonance spectroscopy study of aging in
      parietal white matter: Implications for trials in multiple
      sclerosis.<BR>
SM Leary <I>et al</I>, <I>Magn Reson Imaging</I>
      <STRONG>18</STRONG>, 455-459 (2000).</LI>
<BR>
<BR>

   <LI>Extracellular-Intracellular distribution of glucose and lactate in the
      rat brain assessed noninvasively by diffusion-weighted <SUP>1</SUP>H
      nuclear magnetic resonance spectroscopy <I>in vivo</I>.<BR> 
J Pfeuffer <I>et al</I>, <I>J Cereb Blood Flow Metab</I>
      <STRONG>20</STRONG>, 736-746 (2000).</LI>
<BR>
<BR>

   <LI>MR imaging and localized proton spectroscopy of the precentral gyrus in 
      amyotrophic lateral sclerosis.<BR> 
BC Bowen <I>et al</I>, <I>Am J Neuroradiol</I>
      <STRONG>21</STRONG>, 647-658 (2000).</LI>
<BR>
<BR>

   <LI>Lesion heterogeneity in multiple sclerosis: A study of the relations
      between appearances on T1 weighted images, T1 relaxation times, and
      metabolite concentrations.<BR> 
PA Brex <I>et al</I>, <I>J Neurol Neurosurg Psychiatry</I>
      <STRONG>68</STRONG>, 627-632 (2000).</LI>
<BR>
<BR>

   <LI>Detection of dimethyl sulfone in the human brain by <I>in vivo</I>
      proton magnetic resonance spectroscopy.<BR> 
SE Rose <I>et al</I>, <I>Magn Reson Imaging</I>
      <STRONG>18</STRONG>, 95-98 (2000).</LI>
<BR>
<BR>

   <LI>Regression analysis of metabolite concentrations estimated from
      localized proton MR spectra of active and chronic multiple sclerosis
      lesions.<BR> 
G Helms <I>et al</I>, <I>Magn Reson Med</I>
      <STRONG>43</STRONG>, 102-110 (2000).</LI>
<BR>
<BR>

   <LI>On the reliability of quantitative clinical magnetic resonance
      spectroscopy of the human brain.<BR> 
T Schirmer <I>et al</I>, <I>NMR Biomed</I>
      <STRONG>13</STRONG>, 28-36 (2000).</LI>
<BR>
<BR>

   <LI>A precise and user-independent quantification technique for regional
      comparison of single volume proton MR spectroscopy of the human
      brain.<BR>
G Helms, <I>NMR Biomed</I>
      <STRONG>13</STRONG>, 398-406 (2000).</LI>
<BR>
<BR>

   <LI>Single voxel proton MR spectroscopy methods and applications in
      neuropediatrics.<BR>  
J Frahm <I>et al</I>, <I>Riv Neuroradiol</I>
      <STRONG>13</STRONG>, 7-15 (2000).</LI>
<BR>
<BR>

   <LI>Metabolic changes in brain white matter after perinatal white matter
      injury.<BR>
PS H&uuml;ppi <I>et al</I>, <I>Pediatr Res</I>
      <STRONG>47</STRONG>, 459A (2000).</LI>
<BR>
<BR>

   <LI>Leukoencephalopathy associated with a disturbance in the metabolism of
      polyols.<BR>
MS van der Knaap <I>et al</I>, <I>Ann Neurol</I>
      <STRONG>46</STRONG>, 925-928 (1999).</LI>
<BR>
<BR>

   <LI>Quantitative proton magnetic resonance spectroscopy of cerebral
      metabolic disturbances in patients with MELAS.<BR> 
E Wilichowski <I>et al</I>, <I>Neuropediatrics</I>
      <STRONG>30</STRONG>, 256-263 (1999).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H Magnetic resonance spectroscopy of normal appearing white 
      matter in primary progressive multiple sclerosis.<BR> 
SM Leary <I>et al</I>, <I>J Neurol</I>
      <STRONG>246</STRONG>, 1023-1026 (1999).</LI>
<BR>
<BR>

   <LI>Inflammatory CNS demyelination: Histopathologic correlation with <I>in
	vivo</I> quantitative proton MR spectroscopy.<BR> 
A Bitsch <I>et al</I>, <I>Am J Neuroradiol</I>
      <STRONG>20</STRONG>, 1619-1627 (1999).</LI>
<BR>
<BR>

   <LI>Magnetization transfer attenuation of creatine resonances in localized
      proton MRS of human brain <I>in vivo</I>.<BR> 
G Helms <I>et al</I>, <I>NMR Biomed</I>
      <STRONG>12</STRONG>, 490-494 (1999).</LI>
<BR>
<BR>

   <LI>Brains of creatine kinase deficient mice lack phosphocreatine and
	exhibit an increased NAA level.<BR> 
HJA in 't Zandt <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 174 (2000).</LI>
<BR>
<BR>

   <LI>Absolute quantitative localized <SUP>1</SUP>H MR spectroscopy and MRI
	on the <I>in vivo</I> mouse brain: Effect of genetic background.<BR> 
HJA in 't Zandt <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 180 (2000).</LI>
<BR>
<BR>

   <LI>Quantitation of standard and less prominent metabolites in neonatal
	brain using short TE <SUP>1</SUP>H-MR spectroscopy and advanced model
	fitting.<BR>  
R Kreis <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 587 (2000).</LI>
<BR>
<BR>

   <LI>Quantitative <SUP>1</SUP>H-MRS in early human brain development and
	metabolic changes after perinatal brain injury.<BR> 
PS H&uuml;ppi <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 590 (2000).</LI>
<BR>
<BR>

   <LI>Neuronal dysfunction in the cerebral cortex of the multiple sclerosis
	brain demonstrated with quantitative magnetic resonance spectroscopy
      imaging.<BR> 
P Kapeller <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 628 (2000).</LI>
<BR>
<BR>

   <LI>Quantitative analysis of human and macaque brain metabolites using 3
	Tesla system.<BR> 
N Hattori <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1067 (2000).</LI>
<BR>
<BR>

   <LI>Oral cortisol and psychosocial stress differently alter brain
	metabolism in tree shrews.<BR> 
T Michaelis <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1081 (2000).</LI>
<BR>
<BR>

   <LI>Decreased cerebral N-acetylaspartate correlates with reduced brain
	water apparent diffusion coefficient during delayed energy failure in
	the newborn piglet.<BR> 
JS Thornton <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1091 (2000).</LI>
<BR>
<BR>

   <LI>Metabolite content in cerebral grey and white matter studied with
	short-echo time <SUP>1</SUP>H-MRSI.<BR> 
MA McLean <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1131 (2000).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H MRS, MRI and neuropsychological testing of patients with
	traumatic brain injury at long elapsed time since injury.<BR> 
E Brief <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1138 (2000).</LI>
<BR>
<BR>

   <LI>Changes in the <SUP>1</SUP>H MR spectra of epileptogenic lesions
	treated with the Leksell Gamma Knife (LGK).  Results from a three year 
	period.<BR> 
M H&#225;jek <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1141 (2000).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> drug monitoring of anticonvulsants in the human brain
	using proton MRS.<BR> 
J Braun <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1148 (2000).</LI>
<BR>
<BR>

   <LI>Complete absence of creatine in the adult brain.<BR> 
T Thiel <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1175 (2000).</LI>
<BR>
<BR>

   <LI>N-Acetyl-Aspartate: A marker for viable neurons?<BR> 
T Thiel <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1909 (2000).</LI>
<BR>
<BR>

   <LI>Differential diagnosis of focal brain lesions in children by
	quantitative single-voxel proton magnetic resonance spectroscopy.<BR> 
P Dechent <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1921 (2000).</LI>
<BR>
<BR>

   <LI>Metabolite concentrations of pons, medulla, motor cortex in normal
	human brain using 2D CSI.<BR> 
B Yang <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1937 (2000).</LI>
<BR>
<BR>

   <LI>Metabolite T<SUB>1</SUB> differs within and between regions of normal
	human brain.<BR> 
EE Brief <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1939 (2000).</LI>
<BR>
<BR>

   <LI>Coherent averaging of proton MR spectroscopy data using the residual
      water resonance as intrinsic reference.<BR> 
G Helms <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1948 (2000).</LI>
<BR>
<BR>

   <LI>Inter- and intra-site reproducibility of <I>in vivo</I> metabolite
      quantification with proton magnetic resonance spectroscopic imaging.<BR> 
DT Chard <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>8</STRONG>, 1963 (2000).</LI>
<BR>
<BR>

   <LI>Towards an <I>in vivo</I> neurochemical profile: Quantification of 18
metabolites in short-echo-time <SUP>1</SUP>H NMR spectra of the rat brain.<BR>
J Pfeuffer <I>et al</I>, <I>J Magn Reson</I> <STRONG>141</STRONG>, 
104  (1999).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy in clinically isolated syndromes suggestive of
	multiple sclerosis.<BR>
PA Brex <I>et al</I>, <I>J Neurol Sci</I> <STRONG>166</STRONG>, 
16  (1999).</LI>
<BR>
<BR>

   <LI>Analysis of 1.5 Tesla proton MR spectra of human brain using LCModel
	and an imported basis set.<BR>
G Helms, <I>Magn Reson Imaging</I> <STRONG>17</STRONG>, 
1211  (1999).</LI>
<BR>
<BR>

   <LI>Short echo time single-voxel <SUP>1</SUP>H magnetic resonance
      spectroscopy in magnetic resonance imaging-negative temporal lobe
      epilepsy: Different biochemical profile compared with hippocampal
      sclerosis.<BR> 
FG Woermann <I>et al</I>, <I>Ann Neurol </I> <STRONG>45</STRONG>, 
369 (1999).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H-MRS evidence of neurodegeneration and excess glutamate +
      glutamine in ALS medulla.<BR>  
EP Pioro <I>et al</I>, <I>Neurology</I> <STRONG>53</STRONG>, 
71 (1999).</LI>
<BR>
<BR>

   <LI>Neuronal damage in T1-hypointense multiple sclerosis lesions
      demonstrated <I>in vivo</I> using proton magnetic resonance spectroscopy.
      <BR>  
MAA van Walderveen <I>et al</I>, <I>Ann Neurol</I> <STRONG>46</STRONG>, 
79 (1999).</LI>
<BR>
<BR>

   <LI>Neither short-term nor long-term administration of oral choline alters
      metabolite concentrations in human brain.<BR>  
P Dechent <I>et al</I>, <I>Biol Psychiatry</I> <STRONG>46</STRONG>, 
406 (1999).</LI>
<BR>
<BR>

   <LI>Localized Proton MRS of the human hippocampus: Metabolite
      concentrations and relaxation times.<BR> 
CG Choi <I>et al</I>, <I>Magn Reson Med</I> <STRONG>41</STRONG>, 
204 (1999).</LI>
<BR>
<BR>

   <LI>Magnetic resonance proton spectroscopy of the brain in Wilson's
      disease.<BR> 
E Kraft <I>et al</I>, <I>J Neurol</I> <STRONG>246</STRONG>, 
693 (1999).</LI>
<BR>
<BR>

   <LI>Regional age dependence of human brain metabolites from infancy to
      adulthood as detected by quantitative localized proton MRS.<BR> 
PJW Pouwels <I>et al</I>, <I>Pediatr Res</I> <STRONG>46</STRONG>, 
474 (1999).</LI>
<BR>
<BR>

   <LI>A <SUP>1</SUP>H MRS study of probable Alzheimer's disease and normal
      aging: Implications for longitudinal monitoring of dementia
      progression.<BR> 
SE Rose <I>et al</I>, <I>Magn Reson Imaging</I> <STRONG>17</STRONG>, 
291 (1999).</LI>
<BR>
<BR>

   <LI>Increase of total creatine in human brain after oral supplementation of
      creatine-monohydrate.<BR>  
P Dechent <I>et al</I>, <I>Am J Physiol</I> <STRONG>277</STRONG>, 
R698 (1999).</LI>
<BR>
<BR>

   <LI>Multimodal MR Imaging: Functional, diffusion tensor, and chemical shift 
      imaging in a patient with localization-related epilepsy.<BR>  
K Krakow <I>et al</I>, <I>Epilepsia</I> <STRONG>40</STRONG>, 
1459 (1999).</LI>
<BR>
<BR>

   <LI>Proton MRS of oral creatine supplementation in rats.  Cerebral
      metabolite concentrations and ischemic challenge.<BR>  
T Michaelis <I>et al</I>, <I>NMR Biomed</I> <STRONG>12</STRONG>, 
309 (1999).</LI>
<BR>
<BR>

   <LI>Temporal lobe necrosis following radiation therapy for nasopharyngeal
      carcinoma: <SUP>1</SUP>H MR spectroscopic findings.<BR>  
VFH Chong <I>et al</I>, <I>Int J Radiation Oncology Biol Phys</I>
      <STRONG>45</STRONG>, 699 (1999).</LI>
<BR>
<BR>

   <LI>Proton MR spectroscopy in a child with pyruvate dehydrogenase complex
      deficiency.<BR> 
ME Rubio-Gozalbo <I>et al</I>, <I>Magn Reson Imaging</I>
      <STRONG>17</STRONG>, 939 (1999).</LI>
<BR>
<BR>

   <LI>Quantitative Proton MRS of cerebral multiple sclerosis lesions:
      Regression analysis of metabolite concentrations.<BR> 
G Helms <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 43 (1999).</LI>
<BR>
<BR>

   <LI>Correlation of ADC values with creatine levels in acute ischemic
      stroke.<BR> 
H Rumpel <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 226 (1999).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> <SUP>1</SUP>H NMR spectroscopy of the developing rat
      hippocampus.<BR> 
I Tkac <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 338 (1999).</LI>
<BR>
<BR>

   <LI>Diffusion-weighted<SUP>1</SUP>H NMR spectroscopy of glucose in rat
      brain <I>in vivo</I> at very large b values.<BR> 
J Pfeuffer <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 564 (1999).</LI>
<BR>
<BR>

   <LI>Normalization of quantitative metabolite maps.<BR> 
MA McLean <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 585 (1999).</LI>
<BR>
<BR>

   <LI>Model fitting of <SUP>1</SUP>H-MR spectra of the human brain:
      Incorporation of short-T<SUB>1</SUB> components and evaluation of
      parameterized vs. non-parameterized models.<BR> 
L Hofmann  <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 586 (1999).</LI>
<BR>
<BR>

   <LI>Metabolic changes in quinolinic acid-lesioned rat striatum studied by
      <I>in vivo</I> <SUP>1</SUP>H NMR spectroscopy.<BR> 
I Tkac <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 731 (1999).</LI>
<BR>
<BR>

   <LI>Detection and assignment of phosphocreatine signal <I>in vivo</I> in
      <SUP>1</SUP>H NMR spectra at 9.4 Tesla.<BR> 
J Pfeuffer <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1363 (1999).</LI>
<BR>
<BR>

   <LI>Reduced frontal lobe N-acetyl aspartate in patients with juvenile
      myoclonic epilepsy as detected by localized MRS <I>in vivo</I>.<BR> 
I Savic <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1428 (1999).</LI>
<BR>
<BR>

   <LI>Differences of metabolites in mesial and lateral temporal lobes.<BR> 
Y Wang <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1429 (1999).</LI>
<BR>
<BR>

   <LI>Influence of partial volume effect on  metabolite concentrations in
      multiple sclerosis lesions estimated from localized proton MR
      spectra.<BR>
L Stawiarz <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1439 (1999).</LI>
<BR>
<BR>

   <LI>T<SUB>2</SUB> measurement, magnetization transfer and segmentation of
      extra- and intracellular volumes on discrete "black hole" multiple
      sclerosis lesions.<BR>
G Helms <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1442 (1999).</LI>
<BR>
<BR>

   <LI>Brain proton magnetic resonance spectroscopy of patients with the
      Sj&ouml;gren-Larsson syndrome.<BR>
A Heerschap <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1447 (1999).</LI>
<BR>
<BR>

   <LI>An MR study of lesion heterogeneity in patients with secondary
      progressive MS: Correlation between metabolic concentration, T1
      relaxation time and appearance on T1-weighted MRI.<BR>
PA Brex <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1451 (1999).</LI>
<BR>
<BR>

   <LI>The contribution of magnetic resonance to explaining phenylketonuria
      brain lesions.<BR>
M Dezortov&#225; <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1456 (1999).</LI>
<BR>
<BR>

   <LI>Metabolic asymmetries as an early indicator for temporal lobe epilepsy
      in children. A comparison with EEG and high resolution MRI.<BR>
T Thiel <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1473 (1999).</LI>
<BR>
<BR>

   <LI>Brain metabolite alterations after oral cortisol: A proton MRS study of 
      tree shrews.<BR>
T Michaelis <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1478 (1999).</LI>
<BR>
<BR>

   <LI>Metabolite T<SUB>1</SUB> relaxation differs between and within regions
      of normal human brain.<BR>
E Brief <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1555 (1999).</LI>
<BR>
<BR>

   <LI>Precision of MRS metabolite peak area ratios in human brain at short
      TE.<BR> 
E Brief <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1556 (1999).</LI>
<BR>
<BR>

   <LI>Interactive ROI analysis in <SUP>1</SUP>H-CSI.<BR> 
MA McLean <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1562 (1999).</LI>
<BR>
<BR>

   <LI>Application of LCModel for quality control and quantitative <I>in
	vivo</I> <SUP>1</SUP>H MR spectroscopy by short echo time STEAM
      sequence.<BR> 
M H&#225;jek <I>et al</I>, <I>Proc Intl Soc Magn Reson Med</I>
      <STRONG>7</STRONG>, 1575 (1999).</LI>
<BR>
<BR>


   <LI>Quantitative proton magnetic resonance spectroscopy of childhood
      adrenoleukodystrophy.<BR>  
PJW Pouwels <I>et al</I>, <I>Neuropediatrics</I> <STRONG>29</STRONG>, 
254 (1998).</LI>
<BR>
<BR>

   <LI>Regional metabolite concentrations in human brain as determined by 
quantitative localized proton MRS.<BR>
PJW Pouwels <I>et al</I>, <I>Magn Reson Med</I> <STRONG>39</STRONG>, 
53  (1998).</LI>
<BR>
<BR>

   <LI>Proton T<SUB>2</SUB> relaxation of cerebral metabolites during 
transient global ischemia in rat brain.<BR>
H Fujimori <I>et al</I>, <I>Magn Reson Med</I> <STRONG>39</STRONG>, 647  
(1998).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy of linear nevus sebaceus 
syndrome.<BR>
B Kruse <I>et al</I>, <I>Pediatr Neurol</I> <STRONG>18</STRONG>, 176 
(1998).</LI>
<BR>
<BR>

   <LI>MR spectroscopy in amyotrophic lateral sclerosis / motor neuron 
disease.<BR>
EP Pioro, <I>J Neurol Sci</I> <STRONG>152</STRONG> (Suppl 1), S49 
(1997).</LI>
<BR>
<BR>

   <LI>Stability measure of <SUP>1</SUP>H MRS in normal older adults: 
Implications for longitudinal monitoring of Alzheimer's disease.<BR>
SE Rose <I>et al</I>, <I>Proc ISMRM</I>, 426 (1998).</LI>
<BR>
<BR>

   <LI>Automated production of quantitative metabolite maps from short echo 
time <SUP>1</SUP>H-CSI of the brain.<BR>
MA McLean <I>et al</I>, <I>Proc ISMRM</I>, 626 (1998).</LI>
<BR>
<BR>

   <LI>Does cerebral proton MR spectroscopy reflect tissue alterations and/or 
clinical impairment in HIV-related encephalitis (progressive diffuse 
leukencephalopathy)?<BR>
G-K Elbel <I>et al</I>, <I>Proc ISMRM</I>, 1709 (1998).</LI>
<BR>
<BR>

   <LI>Tailored single voxel short TE MR spectroscopy in temporal lobe 
epilepsy - Absolute quantitation with partial volume correction for 
cerebrospinal fluid.<BR>
FG Woermann <I>et al</I>, <I>Proc ISMRM</I>, 1726 (1998).</LI>
<BR>
<BR>

   <LI>Oral creatine and cerebral metabolism.  Metabolite concentrations and 
ischemic challenge in rat brain.<BR>
T Michaelis <I>et al</I>, <I>Proc ISMRM</I>, 1764 (1998).</LI>
<BR>
<BR>

   <LI>Automated prior knowledge fitting of over-sampled J-resolved 
spectra.<BR>
N Sailasuta <I>et al</I>, <I>Proc ISMRM</I>, 1842 (1998).</LI>
<BR>
<BR>

   <LI><I>In vivo</I> <SUP>1</SUP>H magnetic resonance spectroscopy of the 
spinal cord in humans.<BR>
B Gomez-Anson <I>et al</I>, <I>Proc ISMRM</I>, 1887 (1998).</LI>
<BR>
<BR>

   <LI>Correction of <I>in vivo</I> spectra for individual CSF content in the 
human brain.<BR>
T Schirmer <I>et al</I>, <I>Proc ISMRM</I>, 1900 (1998).</LI>
<BR>
<BR>

   <LI>MR diffusion and proton spectroscopy in cerebral gliomas.<BR>
DP Auer <I>et al</I>, <I>MAGMA</I> (Suppl 1), 8 (1998).</LI>
<BR>
<BR>

   <LI>Diffusion-weighted <I>in vivo</I> <SUP>1</SUP>H NMR spectroscopy of 
brain glucose and metabolites.<BR>
J Pfeuffer <I>et al</I>, <I>MAGMA</I> (Suppl 1), 9 (1998).</LI>
<BR>
<BR>

   <LI>Towards an <I>in vivo</I> neurochemical profile: Quantitation of 
metabolites in ultra-short echo time <SUP>1</SUP>H MRS of rat brain accounting 
for macromolecule resonances.<BR>
J Pfeuffer <I>et al</I>, <I>MAGMA</I> (Suppl 1), 15 (1998).</LI>
<BR>
<BR>

   <LI>Evaluation of metabolite quantitation reliability in <SUP>1</SUP>H 
2D-CSI spectroscopy data using a fully automated analysis routine.<BR>
AZ Damyanovich <I>et al</I>, <I>MAGMA</I> (Suppl 1), 74 (1998).</LI>
<BR>
<BR>

   <LI>Automation of quality control procedures for <I>in vivo</I> MR 
spectroscopy.<BR>
M Burian <I>et al</I>, <I>MAGMA</I> (Suppl 1), 152 (1998).</LI>
<BR>
<BR>

   <LI>Cerebral metabolic changes observed in immunoglobulin treatment of a 
case of Balo's concentric sclerosis.  A proton magnetic resonance 
spectroscopy (<SUP>1</SUP>H MRS) study.<BR>
NR Bolo <I>et al</I>, <I>MAGMA</I> (Suppl 1), 227 (1998).</LI>
<BR>
<BR>

   <LI>Analysis of proton brain spectra from human infants by fitting linear 
combinations of model spectra.<BR>
EB Cady <I>et al</I>, <I>J Magn Reson Anal</I> <STRONG>3</STRONG>, 5 
(1997).</LI>
<BR>
<BR>

   <LI>Improved sensitivity to overlapping multiplet signals in <I>in vivo</I> 
proton spectroscopy using a multiecho volume selective (CPRESS) 
experiment.<BR>
J Hennig <I>et al</I>, <I>Magn Reson Med</I> <STRONG>37</STRONG>, 816 
(1997).</LI>
<BR>
<BR>

   <LI>Differential distribution of NAA and NAAG in human brain as determined 
by quantitative localized proton MRS.<BR>
PJW Pouwels <I>et al</I>, <I>NMR Biomed</I> <STRONG>10</STRONG>, 73
(1997).</LI>
<BR>
<BR>

   <LI>Localized proton magnetic resonance spectroscopy of brain disorders in 
childhood.<BR>
J Frahm <I>et al</I>, <I>Advances in Neurochemistry</I> <STRONG>8</STRONG>, 
329 (1997).</LI>
<BR>
<BR>

   <LI><SUP>1</SUP>H-magnetic resonance spectroscopy in obsessive-compulsive 
disorder: evidence for neuronal loss in the cingulate gyrus and the right 
striatum.<BR>
D Ebert <I>et al</I>, <I>Psychiatry Res</I> <STRONG>74</STRONG>, 173
(1997).</LI>
<BR>
<BR>

   <LI>Grading and therapy monitoring of astrocytomas with <SUP>1</SUP>H 
spectroscopy.<BR>
W Bini <I>et al</I>, <I>Neurocirugia</I> <STRONG>8</STRONG>, 171
(1997).</LI> 
<BR>
<BR>

   <LI>Alterations in brain metabolism after high-dose glucocorticoid therapy: 
a proton magnetic resonance spectroscopy study.<BR>
D Auer <I>et al</I>, <I>Proc ISMRM</I>, 407 (1997).</LI>
<BR>
<BR>

   <LI>Age dependence of human cerebral metabolites in gray matter, white 
matter, and basal ganglia as determined by quantitative localized proton 
MRS.<BR>
PJW Pouwels <I>et al</I>, <I>Proc ISMRM</I>, 482 (1997).</LI>
<BR>
<BR>

   <LI>Proton magnetic resonance spectroscopy in amyotrophic lateral 
sclerosis.<BR>
D Auer <I>et al</I>, <I>Proc ISMRM</I>, 1186 (1997).</LI>
<BR>
<BR>

   <LI>Characteristics of metabolites in multiple sclerosis (MS) plaques by 
quantitative proton MRS.<BR>
L Stawiarz <I>et al</I>, <I>Proc ISMRM</I>, 1192 (1997).</LI>
<BR>
<BR>

   <LI>Cerebral drug effects investigated by <SUP>1</SUP>HMR-spectroscopy in 
volunteers and patients.<BR>
T Burau <I>et al</I>, <I>Proc ISMRM</I>, 1244 (1997).</LI>
<BR>
<BR>

   <LI>Local sensitivity corrrection in quantitative localized proton MRS of 
the human brain.<BR>
G Helms, <I>Proc ISMRM</I>, 1404 (1997).</LI>
<BR>
<BR>

   <LI>Automated quantitation of localized <SUP>1</SUP>H MR spectra <I>in 
vivo</I> at short echo times with baseline distortion.<BR>
SW Provencher, <I>Proc ISMRM</I>, 1411 (1997).</LI>
<BR>
<BR>

   <LI>Localized proton magnetic resonance spectroscopy of cerebral metabolic 
disturbances in children with neuronal ceroid lipofuscinosis.<BR>
K Brockmann <I>et al</I>, <I>Neuropediatrics</I> <STRONG>27</STRONG>, 242 
(1996).</LI>
<BR>
<BR>

   <LI>Localized proton magnetic resonance spectroscopy of a cerebellar tumor
in a two-year-old child.<BR> 
B Wilken <I>et al</I>, <I>Child's Nerv Syst</I> <STRONG>12</STRONG>, 626 
(1996).</LI>
<BR>
<BR>

   <LI>Creatine replacement therapy in guanidinoacetate methyltransferace
deficiency, a novel inborn error of metabolism.<BR> 
S St&ouml;ckler <I>et al</I>, <I>Lancet</I> <STRONG>348</STRONG>, 789
(1996).</LI> 
<BR>
<BR>

   <LI>Grading and therapy monitoring of astrocytomas with
<SUP>1</SUP>H-spectroscopy: Preliminary study.<BR> 
O Speck <I>et al</I>, <I>Anticancer Res</I> <STRONG>16</STRONG>, 1581
(1996).</LI> 
<BR>
<BR>

   <LI>Dynamic uncoupling and recoupling of perfusion and oxidative metabolism
during focal brain activation in man.<BR> 
J Frahm <I>et al</I>, <I>Magn Reson Med</I> <STRONG>35</STRONG>, 143
(1996).</LI> 
<BR>
<BR>

   <LI>Arrested cerebral adrenoleukodystrophy: A clinical and proton magnetic
resonance study in three patients.<BR> 
GC Korenke <I>et al</I>, <I>Pediatr Neurol</I> <STRONG>15</STRONG>, 103
(1996).</LI> 
<BR>
<BR>

   <LI>Localized proton magnetic resonance spectroscopy of cerebral
metabolites.<BR> 
J Frahm <I>et al</I>, <I>Neuropediatrics</I> <STRONG>27</STRONG>, 64
(1996).</LI> 
<BR>
<BR>

   <LI><SUP>1</SUP>H spectroscopy in obsessive compulsive disorder: Evidence
for neuronal loss in the cingulate gyrus and the striatum.<BR> 
O Speck <I>et al</I>, <I>Proc ISMRM</I>, 997 (1996).</LI>
<BR>
<BR>

   <LI>Comparison of short TE single voxel spectroscopic methods using prior 
knowledge fitting.<BR>
N Sailasuta <I>et al</I>, <I>Proc ISMRM</I>, 1187 (1996).</LI>
<BR>
<BR>

   <LI>Differential distribution of NAA and NAAG in human brain as determined
by quantitative localized proton MRS.<BR> 
P Pouwels <I>et al</I>, <I>Proc ESMRMB</I>, 77 (1996).</LI>
<BR>
<BR>

   <LI>Long-term follow up with MRI and proton spectroscopy in Wilson's
disease.<BR> 
E Kraft <I>et al</I>, <I>Proc ESMRMB</I>, 140 (1996).</LI> 
<BR>
<BR>

   <LI>Localized <I>in vivo</I> proton spectroscopy (PRESS) at short echo
times between 8 and 30 ms.<BR> 
T Thiel <I>et al</I>, <I>Proc ESMRMB</I>, 228 (1996).</LI>
<BR>
<BR>

   <LI>Hemimegalencephaly: Localized proton magnetic resonance spectroscopy
<I>in vivo</I>.<BR> 
F Hanefeld <I>et al</I>, <I>Epilepsia</I> <STRONG>36</STRONG>, 1215
(1995).</LI> 
<BR>
<BR>

   <LI>Alteration of intracellular metabolite diffusion in rat brain <I>in
vivo</I> during ischemia and reperfusion.<BR> 
M Wick <I>et al</I>, <I>Stroke</I> <STRONG>26</STRONG>, 1930 (1995).</LI>
<BR>
<BR>

   <LI>Localized proton magnetic resonance spectroscopy of cerebral
abnormalities in children with carbohydrate-deficient glycoprotein 
syndrome.<BR> 
U Holzbach <I>et al</I>, <I>Acta Paediatr</I> <STRONG>84</STRONG>, 781
(1995).</LI> 
<BR>
<BR>

   <LI>Dynamic monitoring of cerebral metabolites during and after transient
global ischemia in rats by quantitative proton NMR spectroscopy <I>in
vivo</I>.<BR> 
Y Nagatomo <I>et al</I>, <I>NMR Biomed</I> <STRONG>8</STRONG>, 265
(1995).</LI> 
<BR>
<BR>

   <LI>Cerebral proton magnetic resonance spectroscopy in Rett syndrome.<BR>
F Hanefeld <I>et al</I>, <I>Neuropediatrics</I> <STRONG>26</STRONG>, 126
(1995).</LI> 
<BR>
<BR>

   <LI><SUP>1</SUP>H MRS in valproate-induced hyperammonemia with
encephalopathy.<BR> 
S Ziyeh <I>et al</I>, <I>Proc SMR</I>, 1836 (1995).</LI>
<BR>
<BR>

   <LI>Automated quantitation of localized <SUP>1</SUP>H MR spectra <I>in
vivo</I>: Capabilities and limitations.<BR> 
SW Provencher <I>et al</I>, <I>Proc SMR</I>, 1952 (1995).</LI>
<BR>
<BR>

   <LI>Improvements in the evaluation of <I>in vivo</I> proton MR spectra
using a fully automated data analysis method (LCModel).<BR> 
W H&auml;nicke <I>et al</I>, <I>Proc SMR</I>, 1953 (1995).</LI>
<BR>
<BR>

   <LI>On the concentration gradient of cerebral metabolites in human gray
matter as determined by quantitative localized proton MRS.<BR> 
PJW Pouwels <I>et al</I>, <I>Proc SMR</I>, 1957 (1995).</LI>
<BR>
<BR>

   <LI>Creatine deficiency in the brain: A new, treatable inborn error of
metabolism.<BR> 
S St&ouml;ckler <I>et al</I>, <I>Pediatr Res</I> <STRONG>36</STRONG>, 409
(1994).</LI> 
<BR>
<BR>

   <LI><I>In Vivo</I> proton magnetic resonance spectroscopy of the brain in a
patient with L-2-hydroxyglutaricacid acidemia.<BR> 
F Hanefeld <I>et al</I>, <I>Pediatr Res</I> <STRONG>35</STRONG>, 614
(1994).</LI> 
<BR>
<BR>

   <LI>Monitoring of cerebral metabolites during forebrain ischemia in rat
<I>in vivo</I> by localized proton MRS.<BR> 
F Prielmeier <I>et al</I>, <I>Proc SMR</I>, 1407 (1994).</LI>
<BR>
<BR>

   <LI>Alterations of brain metabolites in metachromic leukodystrophy as
detected by localized proton magnetic resonance spectroscopy <I>in 
vivo</I>.<BR> 
B Kruse <I>et al</I>, <I>J Neurol</I> <STRONG>241</STRONG>, 68 (1993).</LI>
<BR>
<BR>

   <LI>Quantitative proton MRS <I>in vivo</I> shows cerebral
<I>myo</I>-inositol and cholines to be unchanged in manic-depressive patients
treated with lithium.<BR> 
H Bruhn <I>et al</I>, <I>Proc SMR</I>, 977 (1993).</LI>
<BR>
<BR>

   <LI>On the use of a fully automated data analysis method for <I>in vivo</I>
MRS.  Metabolite concentrations and relaxation times from proton spectra of
human brain.<BR> 
W H&auml;nicke <I>et al</I>, <I>Proc SMR</I>, 1543 (1993).</LI>
<BR>
</UL>
Contact: Stephen Provencher: <A HREF=mailto:sp@lcmodel.CA>sp@lcmodel.CA</A><BR><br>

Last modified: 18 November 2016
</DIV>
</BODY>
</HTML>
